HLA-DRB1 Gene
protein-coding GIFtS: 63
GCID: GC06M032546
|
|
major histocompatibility complex, class II, DR beta 1 (Previous symbol: HLA-DR1B)
| |
Aliases for HLA-DRB1 gene
(According to
1HGNC,
2Entrez Gene,
3UniProtKB/Swiss-Prot,
4UniProtKB/TrEMBL, 5OMIM, 6GeneLoc,
7Ensembl,
8DME,
9miRBase,
and/or 10fRNAdb) About This Section
|
| Aliases |
|---|
| Major Histocompatibility Complex, Class II, DR Beta 11 2 | | DR133 | | HLA-DR1B1 2 5 | | DR143 | | DRw102 3 | | DR163 | | DW2.2/DR2.22 3 | | DR43 | | SS12 5 | | DR53 | | DRB12 | | DR73 | | HLA-DRB2 | | DR83 | | HLA Class II Histocompatibility Antigen, DR-1 Beta Chain2 | | DR93 | | Human Leucocyte Antigen DRB12 | | DRw113 | | Lymphocyte Antigen DRB12 | | DRw83 | | MHC Class II Antigen2 | | HLA-DRB23 | | MHC Class II HLA-DR Beta 1 Chain2 | | Clone P2-Beta-33 | | MHC Class II HLA-DR-Beta Cell Surface Glycoprotein2 | | MHC Class II Antigen DRB1*13 | | MHC Class II HLA-DRw10-Beta2 | | MHC Class II Antigen DRB1*103 | | DR-13 | | MHC Class II Antigen DRB1*113 | | DR-123 | | MHC Class II Antigen DRB1*123 | | DR-133 | | MHC Class II Antigen DRB1*133 | | DR-143 | | MHC Class II Antigen DRB1*143 | | DR-163 | | MHC Class II Antigen DRB1*153 | | DR-43 | | MHC Class II Antigen DRB1*163 | | DR-53 | | MHC Class II Antigen DRB1*33 | | DR-73 | | MHC Class II Antigen DRB1*43 | | DR-83 | | MHC Class II Antigen DRB1*73 | | DR-93 | | MHC Class II Antigen DRB1*83 | | DR13 | | MHC Class II Antigen DRB1*93 | | DR123 | | |
Export aliases for HLA-DRB1 gene to outside databasesPrevious GC identifers: GC06U990049 GC06Md32547 GC06M032317 GC06Md32654 GC06M032656 |
Summaries for HLA-DRB1 gene(According to Entrez Gene,
Tocris Bioscience,
Wikipedia's
Gene Wiki,
PharmGKB,
UniProtKB/Swiss-Prot,
and/or
UniProtKB/TrEMBL)
About This Section
| Entrez Gene summary for HLA-DRB1: HLA-DRB1 belongs to the HLA class II beta chain paralogs. The class II molecule is a heterodimer consisting of an alpha(DRA) and a beta chain (DRB), both anchored in the membrane. It plays a central role in the immune system bypresenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells(APC: B lymphocytes, dendritic cells, macrophages). The beta chain is approximately 26-28 kDa. It is encoded by 6exons. Exon one encodes the leader peptide; exons 2 and 3 encode the two extracellular domains; exon 4 encodes thetransmembrane domain; and exon 5 encodes the cytoplasmic tail. Within the DR molecule the beta chain contains all thepolymorphisms specifying the peptide binding specificities. Hundreds of DRB1 alleles have been described and typingfor these polymorphisms is routinely done for bone marrow and kidney transplantation. DRB1 is expressed at a levelfive times higher than its paralogs DRB3, DRB4 and DRB5. DRB1 is present in all individuals. Allelic variants of DRB1are linked with either none or one of the genes DRB3, DRB4 and DRB5. There are 4 related pseudogenes: DRB2, DRB6,DRB7, DRB8 and DRB9. (provided by RefSeq, Jul 2008) UniProtKB/ace: 2B11_HUMAN, P04229 (see all)Function: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) andpresents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptidesof 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteinsthat access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenousantigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, andfor this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on theirway to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomalcompartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also asource of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In additionto APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents anantigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in theER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigenprocessing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving asmall fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DMvia direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II moleculesuntil primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transportedto the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated byHLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal miroenvironment has been implicated in theregulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis andefficient peptide loading Gene Wiki entry for HLA-DRB1
|
Genomic Views for HLA-DRB1 gene
(According to
GeneLoc and/or
HGNC, and/or
Entrez Gene (NCBI build 37),
and/or miRBase,
Genomic Views according to
UCSC (hg19) and
Ensembl (release 69),
Regulatory elements and Epigenetics data according to
QIAGEN,
SABiosciences, and/or
SwitchGear Genomics) About This Section
| RefSeq DNA sequence:- NT_113891.2 NT_167248.1 NC_000006.11 NC_018917.1 NT_007592.15 NT_167249.1
Regulatory elements: SABiosciences Regulatory transcription factor binding sites in the HLA-DRB1 gene promoter: HOXA3 AML1a p53 CUTL1 CBF-C YY1 CBF-B CBF-A CP1A CBF(2) Other transcription factors
Search SABiosciences Chromatin IP Primers for HLA-DRB1
Epigenetics:
|  | QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat HLA-DRB1 |
Genomic Location: Genomic View: UCSC Golden Path with GeneCards custom track
Entrez Gene cytogenetic band: 6p21.3 Ensembl cytogenetic band: 6p21.32 HGNC cytogenetic band: 6p21.3HLA-DRB1 Gene in genomic location: bands according to Ensembl, locations according to
(and/or Entrez Gene and/or Ensembl if different)

GeneLoc information about chromosome 6 GeneLoc Exon Structure GeneLoc location for GC06M032546: view genomic region
(about GC identifiers)
Start:
|
32,546,546 bp from pter |
End:
|
32,557,625 bp from pter |
Size:
|
11,080 bases |
Orientation:
|
minus strand |
2 alternative locations:
| Chr6-,ALT_REF_LOCI_2 32,475,947-32,528,486 | Chr6-,ALT_REF_LOCI_7 32,510,207-32,722,298 |
|
Proteins for HLA-DRB1 gene
(According to
1UniProtKB,
HORDE,
neXtProt,
Ensembl,
and/or Reactome,
Modification sites according to 2PhosphoSitePlus,
Specific Peptides from DME,
Protein expression images according to data from SPIRE MOPED and PaxDb,
RefSeq according to NCBI,
PDB rendering according to OCA and/or Proteopedia,
Recombinant Proteins
from
EMD Millipore,
R&D Systems,
GenScript,
Enzo Life Sciences,
OriGene,
Novus Biologicals,
Sino Biological,
ProSpec, and/or
Uscn,
Biochemical Assays by
EMD Millipore,
R&D Systems,
OriGene,
GenScript,
Cell Signaling Technology,
Enzo Life Sciences, and/or
Uscn,
Ontologies according to Gene
Ontology Consortium 01 Mar 2013 and
Entrez Gene,
Antibodies by
EMD Millipore,
R&D Systems,
GenScript,
Cell Signaling Technology,
OriGene,
Novus Biologicals,
Thermo Fisher Scientific,
Abcam, and/or
Uscn)
About This Section
| UniProtKB/Swiss-Prot: 2B11_HUMAN, P04229 (See
protein sequence)Recommended Name: HLA class II histocompatibility antigen, DRB1-1 beta chain precursor Size: 266 amino acids; 29914 Da
Subunit: Heterodimer of an alpha and a beta subunit; also referred as MHC class II molecule. In the endoplasmicreticulum (ER) it forms a heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also known as invariantchain or HLA class II histocompatibility antigen gamma chain). In the endosomal/lysosomal system; CD74 undergoessequential degradation by various proteases; leaving a small fragment termed CLIP on each MHC class II molecule. MHCclass II molecule interacts with HLA_DM, and HLA_DO in B-cells, in order to release CLIP and facilitate the binding ofantigenic peptides
Subcellular location: Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-passtype I membrane protein. Golgi apparatus, trans-Golgi network membrane; Single-pass type I membrane protein. Endosomemembrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Late endosomemembrane; Single-pass type I membrane protein. Note=The MHC class II complex transits through a number ofintracellular compartments in the endocytic pathway until it reaches the cell membrane for antigen presentation
6/39 PDB 3D structures from and Proteopedia for HLA-DRB1 (see all 39):1AQD (3D)
  1DLH (3D)
  1FYT (3D)
  1HXY (3D)
  1JWM (3D)
  1JWS (3D)
 
Secondary accessions: A4F5N0 A8K098 O62869 P13758 Q06662 Q30116 Q30117 Q5Y7E9 Q7M2H4 Q95461 Q9BCL7Q9GIK5 Q9MXZ0 Q9MXZ5 Q9TQ91UniProtKB/Swiss-Prot: 2B13_HUMAN, P01912 (See
protein sequence) Recommended Name: HLA class II histocompatibility antigen, DRB1-3 chain precursor Size: 266 amino acids; 30120 Da
Subunit: Heterodimer of an alpha and a beta subunit; also referred as MHC class II molecule. In the endoplasmicreticulum (ER) it forms a heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also known as invariantchain or HLA class II histocompatibility antigen gamma chain). In the endosomal/lysosomal system; CD74 undergoessequential degradation by various proteases; leaving a small fragment termed CLIP on each MHC class II molecule. MHCclass II molecule interacts with HLA_DM, and HLA_DO in B-cells, in order to release CLIP and facilitate the binding ofantigenic peptides
Subcellular location: Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-passtype I membrane protein. Golgi apparatus, trans-Golgi network membrane; Single-pass type I membrane protein. Endosomemembrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Late endosomemembrane; Single-pass type I membrane protein. Note=The MHC class II complex transits through a number ofintracellular compartments in the endocytic pathway until it reaches the cell membrane for antigen presentation
1 PDB 3D structure from and Proteopedia for HLA-DRB1:1A6A (3D)
 UniProtKB/Swiss-Prot: 2B14_HUMAN, P13760 (See
protein sequence) Recommended Name: HLA class II histocompatibility antigen, DRB1-4 beta chain precursor Size: 266 amino acids; 30112 Da
Subunit: Heterodimer of an alpha and a beta subunit; also referred as MHC class II molecule. In the endoplasmicreticulum (ER) it forms a heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also known as invariantchain or HLA class II histocompatibility antigen gamma chain). In the endosomal/lysosomal system; CD74 undergoessequential degradation by various proteases; leaving a small fragment termed CLIP on each MHC class II molecule. MHCclass II molecule interacts with HLA_DM, and HLA_DO in B-cells, in order to release CLIP and facilitate the binding ofantigenic peptides
Subcellular location: Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-passtype I membrane protein. Golgi apparatus, trans-Golgi network membrane; Single-pass type I membrane protein. Endosomemembrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Late endosomemembrane; Single-pass type I membrane protein. Note=The MHC class II complex transits through a number ofintracellular compartments in the endocytic pathway until it reaches the cell membrane for antigen presentation
6/8 PDB 3D structures from and Proteopedia for HLA-DRB1 (see all 8):1D5M (3D)
  1D5X (3D)
  1D5Z (3D)
  1D6E (3D)
  1J8H (3D)
  2SEB (3D)
 
Secondary accessions: O19717 O19739 P13759 Q29875 Q30145 Q9GIX9 Q9GIY4 Q9MY13 Q9XRY5UniProtKB/Swiss-Prot: 2B17_HUMAN, P13761 (See
protein sequence) Recommended Name: HLA class II histocompatibility antigen, DRB1-7 beta chain precursor Size: 266 amino acids; 29822 Da
Subunit: Heterodimer of an alpha and a beta subunit; also referred as MHC class II molecule. In the endoplasmicreticulum (ER) it forms a heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also known as invariantchain or HLA class II histocompatibility antigen gamma chain). In the endosomal/lysosomal system; CD74 undergoessequential degradation by various proteases; leaving a small fragment termed CLIP on each MHC class II molecule. MHCclass II molecule interacts with HLA_DM, and HLA_DO in B-cells, in order to release CLIP and facilitate the binding ofantigenic peptides
Subcellular location: Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-passtype I membrane protein. Golgi apparatus, trans-Golgi network membrane; Single-pass type I membrane protein. Endosomemembrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Late endosomemembrane; Single-pass type I membrane protein. Note=The MHC class II complex transits through a number ofintracellular compartments in the endocytic pathway until it reaches the cell membrane for antigen presentation
Secondary accessions: B0UYW1 O46699 O46872UniProtKB/Swiss-Prot: 2B18_HUMAN, Q30134 (See
protein sequence) Recommended Name: HLA class II histocompatibility antigen, DRB1-8 beta chain precursor Size: 266 amino acids; 30004 Da
Subunit: Heterodimer of an alpha and a beta subunit; also referred as MHC class II molecule. In the endoplasmicreticulum (ER) it forms a heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also known as invariantchain or HLA class II histocompatibility antigen gamma chain). In the endosomal/lysosomal system; CD74 undergoessequential degradation by various proteases; leaving a small fragment termed CLIP on each MHC class II molecule. MHCclass II molecule interacts with HLA_DM, and HLA_DO in B-cells, in order to release CLIP and facilitate the binding ofantigenic peptides
Subcellular location: Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-passtype I membrane protein. Golgi apparatus, trans-Golgi network membrane; Single-pass type I membrane protein. Endosomemembrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Late endosomemembrane; Single-pass type I membrane protein. Note=The MHC class II complex transits through a number ofintracellular compartments in the endocytic pathway until it reaches the cell membrane for antigen presentation
Secondary accessions: O19718 O19788 Q29968 Q30108 Q30115 Q9BCP0 Q9BCP1 Q9BCP2 Q9BD33 Q9TQ37 Q9UIM9UniProtKB/Swiss-Prot: 2B19_HUMAN, Q9TQE0 (See
protein sequence) Recommended Name: HLA class II histocompatibility antigen, DRB1-9 beta chain precursor Size: 266 amino acids; 29826 Da
Subunit: Heterodimer of an alpha and a beta subunit; also referred as MHC class II molecule. In the endoplasmicreticulum (ER) it forms a heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also known as invariantchain or HLA class II histocompatibility antigen gamma chain). In the endosomal/lysosomal system; CD74 undergoessequential degradation by various proteases; leaving a small fragment termed CLIP on each MHC class II molecule. MHCclass II molecule interacts with HLA_DM, and HLA_DO in B-cells, in order to release CLIP and facilitate the binding ofantigenic peptides
Subcellular location: Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-passtype I membrane protein. Golgi apparatus, trans-Golgi network membrane; Single-pass type I membrane protein. Endosomemembrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Late endosomemembrane; Single-pass type I membrane protein. Note=The MHC class II complex transits through a number ofintracellular compartments in the endocytic pathway until it reaches the cell membrane for antigen presentation
Secondary accessions: Q30149UniProtKB/Swiss-Prot: 2B1A_HUMAN, Q30167 (See
protein sequence) Recommended Name: HLA class II histocompatibility antigen, DRB1-10 beta chain precursor Size: 266 amino acids; 30002 Da
Subunit: Heterodimer of an alpha and a beta subunit; also referred as MHC class II molecule. In the endoplasmicreticulum (ER) it forms a heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also known as invariantchain or HLA class II histocompatibility antigen gamma chain). In the endosomal/lysosomal system; CD74 undergoessequential degradation by various proteases; leaving a small fragment termed CLIP on each MHC class II molecule. MHCclass II molecule interacts with HLA_DM, and HLA_DO in B-cells, in order to release CLIP and facilitate the binding ofantigenic peptides
Subcellular location: Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-passtype I membrane protein. Golgi apparatus, trans-Golgi network membrane; Single-pass type I membrane protein. Endosomemembrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Late endosomemembrane; Single-pass type I membrane protein. Note=The MHC class II complex transits through a number ofintracellular compartments in the endocytic pathway until it reaches the cell membrane for antigen presentation
Secondary accessions: P01914 Q9MYF5UniProtKB/Swiss-Prot: 2B1B_HUMAN, P20039 (See
protein sequence) Recommended Name: HLA class II histocompatibility antigen, DRB1-11 beta chain precursor Size: 266 amino acids; 30160 Da
Subunit: Heterodimer of an alpha and a beta subunit; also referred as MHC class II molecule. In the endoplasmicreticulum (ER) it forms a heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also known as invariantchain or HLA class II histocompatibility antigen gamma chain). In the endosomal/lysosomal system; CD74 undergoessequential degradation by various proteases; leaving a small fragment termed CLIP on each MHC class II molecule. MHCclass II molecule interacts with HLA_DM, and HLA_DO in B-cells, in order to release CLIP and facilitate the binding ofantigenic peptides
Subcellular location: Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-passtype I membrane protein. Golgi apparatus, trans-Golgi network membrane; Single-pass type I membrane protein. Endosomemembrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Late endosomemembrane; Single-pass type I membrane protein. Note=The MHC class II complex transits through a number ofintracellular compartments in the endocytic pathway until it reaches the cell membrane for antigen presentation
Secondary accessions: Q30006 Q9GIX8UniProtKB/Swiss-Prot: 2B1C_HUMAN, Q95IE3 (See
protein sequence) Recommended Name: HLA class II histocompatibility antigen, DRB1-12 beta chain precursor Size: 266 amino acids; 29878 Da
Subunit: Heterodimer of an alpha and a beta subunit; also referred as MHC class II molecule. In the endoplasmicreticulum (ER) it forms a heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also known as invariantchain or HLA class II histocompatibility antigen gamma chain). In the endosomal/lysosomal system; CD74 undergoessequential degradation by various proteases; leaving a small fragment termed CLIP on each MHC class II molecule. MHCclass II molecule interacts with HLA_DM, and HLA_DO in B-cells, in order to release CLIP and facilitate the binding ofantigenic peptides
Subcellular location: Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-passtype I membrane protein. Golgi apparatus, trans-Golgi network membrane; Single-pass type I membrane protein. Endosomemembrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Late endosomemembrane; Single-pass type I membrane protein. Note=The MHC class II complex transits through a number ofintracellular compartments in the endocytic pathway until it reaches the cell membrane for antigen presentation
Secondary accessions: A7LA26 B0LUZ6 B6VCX2 B7UDB2 O19585 Q19AF2 Q29771 Q2L9H4 Q2MZ92 Q5EER6 Q5NDB9Q5UT58 Q5Y7G0 Q768U4 Q7YP04 Q861H8 Q95IT6 Q9BD40UniProtKB/Swiss-Prot: 2B1D_HUMAN, Q5Y7A7 (See
protein sequence) Recommended Name: HLA class II histocompatibility antigen, DRB1-13 beta chain precursor Size: 266 amino acids; 30008 Da
Subunit: Heterodimer of an alpha and a beta subunit; also referred as MHC class II molecule. In the endoplasmicreticulum (ER) it forms a heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also known as invariantchain or HLA class II histocompatibility antigen gamma chain). In the endosomal/lysosomal system; CD74 undergoessequential degradation by various proteases; leaving a small fragment termed CLIP on each MHC class II molecule. MHCclass II molecule interacts with HLA_DM, and HLA_DO in B-cells, in order to release CLIP and facilitate the binding ofantigenic peptides
Subcellular location: Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-passtype I membrane protein. Golgi apparatus, trans-Golgi network membrane; Single-pass type I membrane protein. Endosomemembrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Late endosomemembrane; Single-pass type I membrane protein. Note=The MHC class II complex transits through a number ofintracellular compartments in the endocytic pathway until it reaches the cell membrane for antigen presentation
Sequence caution: Sequence=CAB40418.1; Type=Erroneous gene model prediction;
Secondary accessions: A0MWF2 A2ICT1 A4ZXA5 A4ZXA6 A7UHG2 A7X5K7 A8YQE9 B0BK85 B3VTQ3 B5A8Y2 B5A8Y3B5B9V6 B5QSK8 C0LAB5 O02930 O62889 O78047 P79545 Q14280 Q14QT2 Q19K86 Q1G0Z9 Q1KLJ6 Q29673 Q29720Q29722 Q29806 Q29833 Q29874 Q29886 Q2MF40 Q2YHQ2 Q30112 Q3LA93 Q3LA94 Q3LA95 Q3LA96 Q3LA97 Q3LA98Q3LA99 Q3LAA0 Q3LAA1 Q3LAA2 Q3MQ60 Q53IG1 Q56FP2 Q56FP3 Q58F52 Q5K3W2 Q5UBA2 Q5W3L4 Q6REE2 Q6U387Q701T1 Q70Q85 Q768U2 Q7YP03 Q7YQ26 Q7YQA3 Q860E5 Q860H8 Q860Z3 Q861G6 Q861H0 Q861H4 Q8HWQ6 Q8WMA0Q95389 Q95HL1 Q96HZ9 Q9BCP5 Q9BD21 Q9GIP3 Q9GJ25 Q9GJ60 Q9GJF8 Q9GJF9 Q9GJG0 Q9MY45 Q9MY56 Q9TPW3Q9TPW9 Q9TPX4 Q9UBY1 Q9UIN0 Q9XRX1 Q9Y453UniProtKB/Swiss-Prot: 2B1E_HUMAN, Q9GIY3 (See
protein sequence) Recommended Name: HLA class II histocompatibility antigen, DRB1-14 beta chain precursor Size: 266 amino acids; 30139 Da
Subunit: Heterodimer of an alpha and a beta subunit; also referred as MHC class II molecule. In the endoplasmicreticulum (ER) it forms a heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also known as invariantchain or HLA class II histocompatibility antigen gamma chain). In the endosomal/lysosomal system; CD74 undergoessequential degradation by various proteases; leaving a small fragment termed CLIP on each MHC class II molecule. MHCclass II molecule interacts with HLA_DM, and HLA_DO in B-cells, in order to release CLIP and facilitate the binding ofantigenic peptides
Subcellular location: Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-passtype I membrane protein. Golgi apparatus, trans-Golgi network membrane; Single-pass type I membrane protein. Endosomemembrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Late endosomemembrane; Single-pass type I membrane protein. Note=The MHC class II complex transits through a number ofintracellular compartments in the endocytic pathway until it reaches the cell membrane for antigen presentation
Sequence caution: Sequence=CAB45249.1; Type=Erroneous gene model prediction;
Secondary accessions: A0N0W1 A2TGX3 A4ZY86 A5H000 A5HKN8 A7DZP9 A7X5B1 A7X5B7 A7X5E0 A7X5E6 A7X5H8A9JPG0 B1GWE7 B2CR03 B2LVF9 B2NJ29 B2ZCY1 B3VTP8 B5B8U0 B5B9V5 B5LZ25 B6VEL9 B9VRA4 B9X248 O02876O46793 O77969 O78210 Q0PQ39 Q155F7 Q1AP33 Q1JRP3 Q27PR6 Q27PR7 Q29734 Q29770 Q29772 Q29800 Q2A120Q2HZE5 Q2LE76 Q2MJA6 Q2VQU1 Q307W5 Q31636 Q3LA87 Q3LA88 Q3LA89 Q3LA90 Q3LA91 Q3LA92 Q3T919 Q4PRC3Q4PRC5 Q4VZY7 Q56FP1 Q5BM92 Q5U9W6 Q683P7 Q70GL2 Q7YNY9 Q7YQA5 Q860D8 Q860D9 Q860S0 Q861H5 Q861H7Q8MH59 Q8MH60 Q8WLU3 Q95348 Q95HK1 Q95HL0 Q95IG2 Q9GIL5 Q9GIL6 Q9GIY0 Q9GIY1 Q9GIY2 Q9GJ56 Q9GJ57Q9GJ58 Q9TPB6 Q9TPW1 Q9XRY4 Q9Y4H7UniProtKB/Swiss-Prot: 2B1F_HUMAN, P01911 (See
protein sequence) Recommended Name: HLA class II histocompatibility antigen, DRB1-15 beta chain precursor Size: 266 amino acids; 29966 Da
Subunit: Heterodimer of an alpha and a beta subunit; also referred as MHC class II molecule. In the endoplasmicreticulum (ER) it forms a heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also known as invariantchain or HLA class II histocompatibility antigen gamma chain). In the endosomal/lysosomal system; CD74 undergoessequential degradation by various proteases; leaving a small fragment termed CLIP on each MHC class II molecule. MHCclass II molecule interacts with HLA_DM, and HLA_DO in B-cells, in order to release CLIP and facilitate the binding ofantigenic peptides
Subcellular location: Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-passtype I membrane protein. Golgi apparatus, trans-Golgi network membrane; Single-pass type I membrane protein. Endosomemembrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Late endosomemembrane; Single-pass type I membrane protein. Note=The MHC class II complex transits through a number ofintracellular compartments in the endocytic pathway until it reaches the cell membrane for antigen presentation
Miscellaneous: The chain shown constituted about 70% of a pool of at least seven similar beta chains
3 PDB 3D structures from and Proteopedia for HLA-DRB1:1BX2 (3D)
  1YMM (3D)
  2WBJ (3D)
 
Secondary accessions: Q29790 Q29975 Q30142 Q30166 Q32MY7 Q56FN9 Q5Y7B0 Q5Y7B9UniProtKB/Swiss-Prot: 2B1G_HUMAN, Q29974 (See
protein sequence) Recommended Name: HLA class II histocompatibility antigen, DRB1-16 beta chain precursor Size: 266 amino acids; 30030 Da
Subunit: Heterodimer of an alpha and a beta subunit; also referred as MHC class II molecule. In the endoplasmicreticulum (ER) it forms a heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also known as invariantchain or HLA class II histocompatibility antigen gamma chain). In the endosomal/lysosomal system; CD74 undergoessequential degradation by various proteases; leaving a small fragment termed CLIP on each MHC class II molecule. MHCclass II molecule interacts with HLA_DM, and HLA_DO in B-cells, in order to release CLIP and facilitate the binding ofantigenic peptides
Subcellular location: Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-passtype I membrane protein. Golgi apparatus, trans-Golgi network membrane; Single-pass type I membrane protein. Endosomemembrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Late endosomemembrane; Single-pass type I membrane protein. Note=The MHC class II complex transits through a number ofintracellular compartments in the endocytic pathway until it reaches the cell membrane for antigen presentation
Secondary accessions: A7X5J4 O98212 Q0PGR5 Q29792 Q30120 Q30159 Q30200 Q3HUP9 Q3KTM1 Q3LA84 Q6T865Q95383Explore the universe of human proteins at neXtProt for HLA-DRB1: NX_Q29974
Post-translational modifications:
Ubiquitinated by MARCH1 and MARCH8 at Lys-254 leading to sorting into the endosome system and down-regulation of MHCclass II (Probable)1
View modification sites using PhosphoSitePlus2 (HLA-DRB4)View neXtProt modification sites for NX_Q29974 HLA-DRB1 Protein expression data from MOPED and PaxDb: About this image 
 REFSEQ proteins (2 alternative transcripts):
NP_001230894.1 NP_002115.2 ENSEMBL proteins: ENSP00000353099 Reactome Protein details: Q30167 Q5Y7A7 P04229 Q9TQE0 Q9GIY3 P01911 Q29974 P20039 Q95IE3 P01912 P13760 Q30134 P13761 Human Recombinant Protein Products for HLA-DRB1:
Gene Ontology (GO): 5/17 cellular component terms (GO ID links to tree view) (see all 17): About this table
HLA-DRB1 for ontologies About GeneDecksing
HLA-DRB1 Antibody Products: Assay Products for HLA-DRB1: |
Protein
Domains / Families for HLA-DRB1 gene(According to InterPro, ProtoNet,
UniProtKB, and/or BLOCKS,
Sets of similar genes according to GeneDecks)
About This Section
|
HLA-DRB1 for domains About GeneDecksing
5/7 InterPro domains/families (see all 7):Graphical View of Domain Structure for InterPro Entry P04229Graphical View of Domain Structure for InterPro Entry P01912Graphical View of Domain Structure for InterPro Entry P13760Graphical View of Domain Structure for InterPro Entry P13761Graphical View of Domain Structure for InterPro Entry Q30134Graphical View of Domain Structure for InterPro Entry Q9TQE0Graphical View of Domain Structure for InterPro Entry Q30167Graphical View of Domain Structure for InterPro Entry P20039Graphical View of Domain Structure for InterPro Entry Q95IE3Graphical View of Domain Structure for InterPro Entry Q5Y7A7Graphical View of Domain Structure for InterPro Entry Q9GIY3Graphical View of Domain Structure for InterPro Entry P01911Graphical View of Domain Structure for InterPro Entry Q29974ProtoNet protein and cluster: P04229 2 Blocks protein families: IPB000353 Class II histocompatibility antigen IPB003597 Immunoglobulin C-type
UniProtKB/Swiss-Prot: 2B11_HUMAN, P04229Similarity: Belongs to the MHC class II familySimilarity: Contains 1 Ig-like C1-type (immunoglobulin-like) domainUniProtKB/Swiss-Prot: 2B13_HUMAN, P01912Similarity: Belongs to the MHC class II familySimilarity: Contains 1 Ig-like C1-type (immunoglobulin-like) domainUniProtKB/Swiss-Prot: 2B14_HUMAN, P13760Similarity: Belongs to the MHC class II familySimilarity: Contains 1 Ig-like C1-type (immunoglobulin-like) domainUniProtKB/Swiss-Prot: 2B17_HUMAN, P13761Similarity: Belongs to the MHC class II familySimilarity: Contains 1 Ig-like C1-type (immunoglobulin-like) domainUniProtKB/Swiss-Prot: 2B18_HUMAN, Q30134Similarity: Belongs to the MHC class II familySimilarity: Contains 1 Ig-like C1-type (immunoglobulin-like) domainUniProtKB/Swiss-Prot: 2B19_HUMAN, Q9TQE0Similarity: Belongs to the MHC class II familySimilarity: Contains 1 Ig-like C1-type (immunoglobulin-like) domainUniProtKB/Swiss-Prot: 2B1A_HUMAN, Q30167Similarity: Belongs to the MHC class II familySimilarity: Contains 1 Ig-like C1-type (immunoglobulin-like) domainUniProtKB/Swiss-Prot: 2B1B_HUMAN, P20039Similarity: Belongs to the MHC class II familySimilarity: Contains 1 Ig-like C1-type (immunoglobulin-like) domainUniProtKB/Swiss-Prot: 2B1C_HUMAN, Q95IE3Similarity: Belongs to the MHC class II familySimilarity: Contains 1 Ig-like C1-type (immunoglobulin-like) domainUniProtKB/Swiss-Prot: 2B1D_HUMAN, Q5Y7A7Similarity: Belongs to the MHC class II familySimilarity: Contains 1 Ig-like C1-type (immunoglobulin-like) domainUniProtKB/Swiss-Prot: 2B1E_HUMAN, Q9GIY3Similarity: Belongs to the MHC class II familySimilarity: Contains 1 Ig-like C1-type (immunoglobulin-like) domainUniProtKB/Swiss-Prot: 2B1F_HUMAN, P01911Similarity: Belongs to the MHC class II familySimilarity: Contains 1 Ig-like C1-type (immunoglobulin-like) domainUniProtKB/Swiss-Prot: 2B1G_HUMAN, Q29974Similarity: Belongs to the MHC class II familySimilarity: Contains 1 Ig-like C1-type (immunoglobulin-like) domain |
Function for HLA-DRB1 gene
(According to 1UniProtKB,
Genatlas,
LifeMap Discovery™,
IUBMB, and/or
2DME,
Human phenotypes from GenomeRNAi,
Animal models from MGI Mar 06 2013,
inGenious Targeting Laboratory,
bound targets from SABiosciences,
miRNA Gene Targets from miRTarBase,
shRNA from
OriGene,
Sirion Biotech,
RNAi from
EMD Millipore,
siRNAs from
OriGene,
QIAGEN,
microRNA from QIAGEN,
Gene Editing from DNA2.0,
Sirion Biotech,
Clones from EMD Millipore,
OriGene,
SwitchGear Genomics,
GenScript,
Sino Biological,
DNA2.0,
and Vector BioLabs,
Cell Lines from GenScript,
LifeMap BioReagents,
Sirion Biotech,
In Situ Hybridization Assays from Advanced Cell Diagnostics,
Ontologies according to Gene Ontology Consortium 01 Mar 2013 via
Entrez Gene.)
About This Section
| Molecular Function: UniProtKB/ace Summary: 2B11_HUMAN, P04229 (see all)Function: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) andpresents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptidesof 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteinsthat access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenousantigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, andfor this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on theirway to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomalcompartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also asource of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In additionto APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents anantigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in theER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigenprocessing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving asmall fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DMvia direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II moleculesuntil primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transportedto the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated byHLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal miroenvironment has been implicated in theregulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis andefficient peptide loading Genatlas biochemistry entry for HLA-DRB1:HLA-DR,beta 1 chain,determining DR1,3,4,5 etc
Gene Ontology (GO): 2 molecular function terms (GO ID links to tree view): About this table
HLA-DRB1 for ontologies About GeneDecksing
Animal Models:
Clone Products: |  | Browse Clones for the Expression of Recombinant Proteins Available from EMD Millipore | |  | OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for HLA-DRB1 OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for HLA-DRB1 (see all 5) OriGene custom cloning services - gene synthesis, subcloning, mutagenesis,
variant library, vector shuttling 
| |  | GenScript: all cDNA clones in your preferred vector: HLA-DRB1 (NM_002124) | |  | Browse Sino Biological Human cDNA Clones | |  | DNA2.0 Custom Codon Optimized Gene
Synthesis Service for HLA-DRB1 | |  | Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat HLA-DRB1  |
In Situ Assay Products: |
| Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for HLA-DRB1 |
|
Pathways & Interactions for HLA-DRB1 gene
(Pathways according to
EMD Millipore,
R&D Systems,
Cell Signaling Technology,
KEGG,
PharmGKB,
BioSystems,
Reactome,
Tocris Bioscience,
GeneGo (Thomson Reuters),
QIAGEN,
and/or UniProtKB,
Sets of similar genes according to GeneDecks,
Interaction Networks according to
SABiosciences,
and/or STRING,
Interactions according to 1UniProtKB,
2MINT,
3I2D, and/or
4STRING,
with links to IntAct and
Ensembl,
Ontologies according to Gene Ontology Consortium 01 Mar 2013 via
Entrez Gene).
About This Section
| Unified GeneCards pathways - 5/34 super-pathways (see all 34) About this table  See pathways by source
| Super-pathway | contained gene-specific pathways |
|---|
| 1 | Transport of MHC II:Ii complex along Golgi to TGN | | | 2 | Translocation of ZAP-70 to Immunological synapse | | | 3 | Cytokine Signaling in Immune system | | | 4 | Immune System | | | 5 | Interferon gamma signaling | |
Pathway sources See GeneCards unified pathways Show all pathways
5/6 EMD Millipore Pathways for HLA-DRB1 (see all 6) 5/12 Downloadable PowerPoint Slides of QIAGEN Pathway Central Maps for HLA-DRB1 (see all 12) 5/6 GeneGo (Thomson Reuters) Pathways for HLA-DRB1 (see all 6) 5 BioSystems Pathways for HLA-DRB1 
5/20
Reactome Pathways for HLA-DRB1 (see all 20)
5/18
Kegg Pathways (Kegg details for HLA-DRB1) (see all 18):
HLA-DRB1 for pathways About GeneDecksing
Interactions:
SABiosciences Gene Network CentralTM Interacting Genes and Proteins Network for HLA-DRB1
STRING Interaction
Network Preview (showing 5 interactants - click image to see 25)
 5/198 Interacting proteins for HLA-DRB1 (P019122 P042292 ENSP000003530994 Q299742, 3) via UniProtKB, MINT, STRING, and/or I2D (see all 198)About this table
Gene Ontology (GO): 5/18 biological process terms (GO ID links to tree view) (see all 18): About this table | GO ID | Qualified GO term | Evidence | PubMed IDs |
|---|
| GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response |
ISS | -- | | GO:0002437 | inflammatory response to antigenic stimulus |
ISS | -- | | GO:0002455 | humoral immune response mediated by circulating immunoglobulin |
ISS | -- | | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
-- | -- | | GO:0006955 | immune response |
NAS | -- |
HLA-DRB1 for ontologies About GeneDecksing
|
Drugs & Compounds for HLA-DRB1 gene(Chemical Compounds according to UniProtKB, Enzo Life Sciences,
EMD Millipore, Tocris Bioscience
HMDB,
BitterDB, and/or
Novoseek, and Drugs according to
DrugBank,
Enzo Life Sciences, and/or
PharmGKB, with drugs/clinical trials/news
search links to CenterWatch)
About This Section
|
HLA-DRB1 for compounds About GeneDecksing
Browse Tocris compounds for HLA-DRB1
1 DrugBank Compound for HLA-DRB1 About this table
10/17 Novoseek chemical compound relationships for HLA-DRB1 gene (see all 17) About this table
| Compound |
-log (P-Val) |
Hits |
PubMed IDs for Articles with Shared Sentences (# sentences) |
| dr-10 |
77.3 |
6 |
7780115 (1), 9550403 (1), 8754259 (1), 10626740 (1) |
| dr-16 |
73.6 |
1 |
9243764 (1) |
| dpa 1 |
73.1 |
5 |
8782076 (1), 8863870 (1), 17060025 (1), 10616003 (1) (see all 5) |
| oligonucleotide |
53.4 |
22 |
8117375 (1), 12823773 (1), 15865503 (1), 18718089 (1) (see all 20) |
| gold sodium thiomalate |
36 |
2 |
11093435 (1) |
| valine |
30.5 |
4 |
9098452 (1), 8500529 (1), 10439317 (1), 2369430 (1) |
| amino acid |
19.7 |
1 |
1533151 (1) |
| c-peptide |
4.17 |
1 |
15388265 (1) |
| atp |
3.36 |
2 |
12658812 (2) |
| lysine |
0 |
2 |
7738179 (1), 7612412 (1) |
Search CenterWatch for drugs/clinical trials and news about HLA-DRB1 / 2B1G 
|
Transcripts for HLA-DRB1 gene(Secondary structures according to
fRNAdb,
GenBank/EMBL/DDBJ Accessions according to
Unigene
(Build 235 Homo sapiens; Mar 10 2013) or GenBank, RefSeq according to Entrez Gene,
DOTS (version 10), and/or
AceView,
transcript ids from Ensembl
with links to UCSC,
exon structure from GeneLoc,
alternative splicing isoforms according to ASD and/or
ECgene,
RNAi Products from
EMD Millipore,
siRNAs from
OriGene,
QIAGEN,
shRNA from
OriGene,
Sirion Biotech,
microRNA from QIAGEN,
Tagged/untagged cDNA clones from
OriGene,
SwitchGear Genomics,
GenScript,
DNA2.0,
Vector BioLabs,
Primers from
OriGene,
SABiosciences, and/or
QIAGEN
) About This Section
| REFSEQ mRNAs for HLA-DRB1 gene (2 alternative transcripts): NM_001243965.1 NM_002124.3 Unigene Clusters for HLA-DRB1: Major histocompatibility complex, class II, DR beta 1 Hs.534322 [show with all ESTs], Hs.696211 [show with all ESTs], Hs.736560 [show with all ESTs]Unigene Representative Sequences: AK290388, AK225690, BG4845131 Ensembl transcript including schematic representation, and UCSC links where relevant: ENST00000360004(uc021yvx.1 uc003obp.4 uc011dqb.1 uc011dqc.1)
Clone Products: |  | OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for HLA-DRB1 OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for HLA-DRB1 (see all 5) OriGene custom cloning services - gene synthesis, subcloning, mutagenesis,
variant library, vector shuttling 
| |  | GenScript: all cDNA clones in your preferred vector: HLA-DRB1 (NM_002124) | |  | DNA2.0 Custom Codon Optimized Gene
Synthesis Service for HLA-DRB1 | |  | Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat HLA-DRB1  |
Additional cDNA sequence: AF004817.1 AJ580838.1 D86415.1 M15070.1 M17386.1 M25266.1 M27014.1 M59798.1 24/70 DOTS entries (see all 70): DT.92410344 DT.92028787 DT.91706875 DT.95164729 DT.92047682 DT.100776434 DT.95164752 DT.92382901 DT.95164731 DT.121314547 DT.87079048 DT.40115364 DT.100781798 DT.100778733 DT.100650571 DT.100766538 DT.121314746 DT.92380890 DT.121314807 DT.95230813 DT.97857272 DT.95164743 DT.91802323 DT.92467723 24/89 AceView cDNA sequences (see all 89): M16731 X02902 BV207240 M17381 BV183568 BV201637 L42143 AH002891 AJ245881 AF291675 AJ297586 BV207185 M15073 AJ536121 BC024269 BV207249 BV207188 U84892 BV207191 X12544 BV200472 BV207037 BV200469 BV207182 GeneLoc Exon Structure
|
Expression for HLA-DRB1 gene
(RNA expression data according to
H-InvDB,
NONCODE,
miRBase, and
RNAdb,
Expression images according to data from
BioGPS,
Illumina Human BodyMap, and
CGAP
SAGE,
Sets of similar genes according to GeneDecks,
in vivo and in vitro expression data from LifeMap Discovery™,
plus additional links to
Genevestigator, and/or
SOURCE, and/or
BioGPS, and/or
UniProtKB,
PCR Arrays from
SABiosciences,
Primers from
OriGene,
SABiosciences, and/or
QIAGEN,
In Situ Hybridization Assays from Advanced Cell Diagnostics)
About This Section
| HLA-DRB1 expression in normal human tissues (normalized intensities) See probesets specificity/sensitivity at GeneAnnot About this imageBioGPS CGAP TAG: ACAGCGCTGA
 About this image See HLA-DRB1 Protein Expression from SPIRE MOPED and PaxDB Genevestigator expression for HLA-DRB1
SOURCE GeneReport for Unigene clusters: Hs.534322 Hs.696211 Hs.736560 SABiosciences Expression via Pathway-Focused PCR Arrays including HLA-DRB1:
Primer Products: |  | OriGene genome-wide validated SYBR primer pairs in human, mouse, rat for HLA-DRB1 Browse OriGene validated miRNA SYBR primer pairs
| |  | SABiosciences RT2 qPCR Primer Assay in human, mouse, rat HLA-DRB1 | |  | QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat HLA-DRB1 | |  | QIAGEN QuantiFast Probe-based Assays in human, mouse, rat HLA-DRB1 | In Situ Assay Products: |
| Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for HLA-DRB1 |
Orthologs for HLA-DRB1 gene
(Orthologs according to
1,2HomoloGene (2older version, for species not in 1newer version),
3euGenes,
4SGD
,
5MGI Mar 06 2013,
with possible further links to
Flybase
and/or
WormBase,
and/or
6Ensembl pan taxonomic compara ,
Gene Trees according to Ensembl and
TreeFam)
About This Section
|
This gene was present in the common ancestor of chordates.
Orthologs for HLA-DRB1 gene from 3/9 species (see all 9) About this table
ENSEMBL Gene Tree for HLA-DRB1 (if available) TreeFam Gene Tree for HLA-DRB1 (if available)  |
Paralogs for HLA-DRB1 gene(Paralogs according to
1HomoloGene, 2Ensembl, and 3SIMAP, Pseudogenes according to 4Pseudogene.org Build 68) About This Section
| Paralogs for HLA-DRB1 gene
- HLA-DRB52 HLA-DQA12 HLA-DPA12 HLA-DQB12 HLA-DRA2 HLA-DOB2 HLA-DMA2 HLA-DQB22
- ENSG000002489932 HLA-DOA2 HLA-DMB2 HLA-DQA22 HLA-DPB12
18/233 SIMAP similar genes for HLA-DRB1 using alignment to 1823 protein entries: 2B11_HUMAN F8RHK4_HUMAN L0BXK2_HUMAN F2VPA0_HUMAN Q45FZ4_HUMAN C9WEW4_HUMAN B2NJ27_HUMAN O78048_HUMAN F2X660_HUMAN Q5Y7D7_HUMAN Q000J6_HUMAN Q30156_HUMAN D4P2X4_HUMAN Q4U4M7_HUMAN G0WVD4_HUMAN F8RHJ4_HUMAN D3JV11_HUMAN F2X651_HUMAN A7UNZ8_HUMAN H8WV87_HUMAN G8HT85_HUMAN G0ZTB0_HUMAN Q6RCP8_HUMAN G9HRQ9_HUMAN B0LUU3_HUMAN B1GVZ5_HUMAN Q5U9D1_HUMAN Q3LAC2_HUMAN A0ZXX2_HUMAN G5EM96_HUMAN D5FID9_HUMAN Q29672_HUMAN F8RHJ2_HUMAN A7X5L2_HUMAN G0Z5I8_HUMAN C8XTJ1_HUMAN A3F923_HUMAN Q5QQ11_HUMAN A9JJF6_HUMAN Q8MGZ7_HUMAN A0AQY0_HUMAN F8R8M8_HUMAN E3SWP1_HUMAN C8CHC4_HUMAN B5ABX7_HUMAN B3GDG5_HUMAN D0VE46_HUMAN Q9Y454_HUMAN F2X658_HUMAN E1V2J5_HUMAN I2G7Y5_HUMAN C9WEW2_HUMAN F8RHJ7_HUMAN E2GJN9_HUMAN D5FIE1_HUMAN Q9TPE1_HUMAN A7UP07_HUMAN C9EIB6_HUMAN C8XTL2_HUMAN Q7YPZ5_HUMAN F8SY63_HUMAN D7NPQ7_HUMAN Q3LTJ6_HUMAN O77971_HUMAN B3GV30_HUMAN D3JV16_HUMAN Q8SNB5_HUMAN Q6TKG7_HUMAN F8R8M5_HUMAN A7UHG7_HUMAN G9FJH9_HUMAN F2VNW5_HUMAN K0P797_HUMAN C9E1J0_HUMAN C5J8E7_HUMAN F2X669_HUMAN F8RHM2_HUMAN I7C0V1_HUMAN G1EN15_HUMAN Q0Z850_HUMAN Q6DV47_HUMAN Q3LAB7_HUMAN B0LUD6_HUMAN Q9MY83_HUMAN Q9BD47_HUMAN C8C9W0_HUMAN C0LAC2_HUMAN Q3LAA6_HUMAN F8TVR8_HUMAN A0AQY5_HUMAN 2B1B_HUMAN Q6RCP9_HUMAN G1EMZ0_HUMAN F8LSY3_HUMAN H8WV57_HUMAN C8XTM2_HUMAN J9Z200_HUMAN G1EMZ4_HUMAN I7KP34_HUMAN F2VP99_HUMAN E0WN71_HUMAN A8C5I7_HUMAN C8ZLD6_HUMAN A7UP08_HUMAN 2B1A_HUMAN D3JV06_HUMAN J7FR35_HUMAN I6NXM9_HUMAN G9I2P2_HUMAN C6L829_HUMAN D5FID7_HUMAN Q860S9_HUMAN E9LIR7_HUMAN E1XUI4_HUMAN B0LUU4_HUMAN Q7YQA8_HUMAN C8C9V6_HUMAN A7X5H1_HUMAN Q1JRP4_HUMAN F8RHK7_HUMAN Q95HK4_HUMAN G0Z8G3_HUMAN F5A3L2_HUMAN I7KSM4_HUMAN Q8MGY2_HUMAN I6Z114_HUMAN Q5Y7D1_HUMAN Q861H2_HUMAN A1A414_HUMAN O19723_HUMAN Q9TQ70_HUMAN Q9TQ43_HUMAN Q29686_HUMAN Q9BCS7_HUMAN Q3LRY0_HUMAN G8GB45_HUMAN A1A418_HUMAN Q7YQ31_HUMAN I6NS51_HUMAN D5FIC8_HUMAN Q3LTJ8_HUMAN J7F8K2_HUMAN E3SGD2_HUMAN E7BYD8_HUMAN B2G3D1_HUMAN E1V2J7_HUMAN F1CCQ3_HUMAN A7UP05_HUMAN B1PL08_HUMAN C8XTM3_HUMAN Q861A4_HUMAN Q53YS1_HUMAN I2B1C4_HUMAN H2BDS7_HUMAN F1CCN1_HUMAN G4XPL9_HUMAN A7L3U7_HUMAN Q9TP93_HUMAN F2X659_HUMAN K0P2W4_HUMAN D7NST1_HUMAN C8XTI8_HUMAN C9E868_HUMAN E3SGD4_HUMAN Q95HK8_HUMAN F2X655_HUMAN F2VNV8_HUMAN O19730_HUMAN C5IZL0_HUMAN D2D3G8_HUMAN E5RVA0_HUMAN Q4U4M5_HUMAN B2NJ38_HUMAN Q95381_HUMAN D3U4F2_HUMAN D0VE52_HUMAN Q4U3X3_HUMAN D5FID5_HUMAN Q9GJ37_HUMAN K4ULG7_HUMAN F8RHN2_HUMAN D5FUG5_HUMAN G1EN12_HUMAN C9WEX4_HUMAN H2A0A5_HUMAN F4YZX4_HUMAN Q861F8_HUMAN F0VRV6_HUMAN C0LAB9_HUMAN F4YUB1_HUMAN Q9GJM1_HUMAN Q9BCP4_HUMAN Q29744_HUMAN L0HNF8_HUMAN F4NBM1_HUMAN A7UMH5_HUMAN H8WV76_HUMAN A7UP09_HUMAN B9WPM5_HUMAN F8SL09_HUMAN A9JQM0_HUMAN I6NVU2_HUMAN F4NBL5_HUMAN E2FZH3_HUMAN F8SL10_HUMAN F2X665_HUMAN D5FIF2_HUMAN Q29688_HUMAN D6CJC2_HUMAN C8XTM1_HUMAN C8XTL5_HUMAN I2CSG7_HUMAN F2X663_HUMAN Q3T976_HUMAN Q8SNC0_HUMAN L0BXM1_HUMAN L0BX03_HUMAN C8XTI6_HUMAN B2ZGJ0_HUMAN 2B1E_HUMAN Q8WLU0_HUMAN C8XTK7_HUMAN A7DZ90_HUMAN A0N0W2_HUMAN O77970_HUMAN F1CCN4_HUMAN D7R0U4_HUMAN Q29727_HUMAN K4HPL6_HUMAN F1CCQ5_HUMAN Q95HL4_HUMAN Q31643_HUMAN 2B18_HUMAN Q9TQ57_HUMAN Q50EW5_HUMAN C8XTJ0_HUMAN C3VN82_HUMAN Q8NEI3_HUMAN F4NBL0_HUMAN H8WV90_HUMAN O78044_HUMAN D9U3I3_HUMAN F2X656_HUMAN F1C3G9_HUMAN C8XTJ5_HUMAN F8SY65_HUMAN A0T4C2_HUMAN Q95HK2_HUMAN A8D9Z0_HUMAN Q9TQ53_HUMAN J7FK30_HUMAN D3JV07_HUMAN Q29713_HUMAN A7XPK7_HUMAN Q6QJL9_HUMAN F8RHM3_HUMAN Q9GIL7_HUMAN Q9UM38_HUMAN Q9TQ50_HUMAN G1EN02_HUMAN F2VNV4_HUMAN D9IFQ3_HUMAN H2BDS2_HUMAN I2G7Y7_HUMAN F6KS27_HUMAN G1EN09_HUMAN H2BEB5_HUMAN F1CCP9_HUMAN D9IFQ2_HUMAN D5G2J6_HUMAN D7GN73_HUMAN D7R0V0_HUMAN F8R8M7_HUMAN Q6RCQ0_HUMAN Q9BCN9_HUMAN Q8WLU1_HUMAN L0BVW5_HUMAN 2B1G_HUMAN F4YZW4_HUMAN D0VE56_HUMAN C9WEY2_HUMAN A0AQZ4_HUMAN D3U4F0_HUMAN Q8HWG5_HUMAN Q6QE68_HUMAN D5FIE9_HUMAN Q9TQ77_HUMAN E7DVC3_HUMAN D3JV18_HUMAN Q9TQ62_HUMAN F4YZX5_HUMAN C8XTM8_HUMAN H8WV99_HUMAN C8CJD7_HUMAN D5L9E8_HUMAN G9FJH6_HUMAN E0Z0A8_HUMAN D2SSL5_HUMAN H0YIT9_HUMAN Q8MH61_HUMAN G8GB38_HUMAN C0LAC1_HUMAN Q29725_HUMAN D5FIE3_HUMAN L7UUL9_HUMAN F8SL12_HUMAN Q8HWN2_HUMAN D7R0U9_HUMAN B2CKL1_HUMAN L0BVK5_HUMAN C3W973_HUMAN O19696_HUMAN D0EVN7_HUMAN F8STB2_HUMAN Q6QUQ1_HUMAN C9WEV6_HUMAN C0LAB7_HUMAN B2RG90_HUMAN F4YUB0_HUMAN D0VE53_HUMAN O78161_HUMAN L0HQC7_HUMAN H8WV95_HUMAN A5I890_HUMAN E1Y6P8_HUMAN Q3LAB1_HUMAN C8CJD0_HUMAN Q30178_HUMAN Q30161_HUMAN Q9TQ40_HUMAN B5D5S9_HUMAN Q95HK9_HUMAN E5FPU1_HUMAN F4NBL6_HUMAN D4P2X3_HUMAN A4Q970_HUMAN Q29786_HUMAN J7K1E0_HUMAN E5DCR3_HUMAN Q8TB62_HUMAN F8R1D4_HUMAN C8CBI3_HUMAN D2D3G3_HUMAN G1EMZ8_HUMAN E1XUD4_HUMAN A2VBX2_HUMAN C8CJA7_HUMAN D7RII0_HUMAN Q4U0U6_HUMAN A1A413_HUMAN G9HRN0_HUMAN E3SGD1_HUMAN D7RIG2_HUMAN 2B1D_HUMAN Q0PQ40_HUMAN E1V2J9_HUMAN H6SSQ5_HUMAN F5BR67_HUMAN C6L820_HUMAN G1EN21_HUMAN F4YZW9_HUMAN E1U686_HUMAN E9LT12_HUMAN I6SJA4_HUMAN F4NBM7_HUMAN H6A2E3_HUMAN Q9TQD8_HUMAN G9F9T8_HUMAN C9WEX1_HUMAN A0N0W0_HUMAN C1KBK0_HUMAN Q6RCM2_HUMAN A7UP03_HUMAN H8WV85_HUMAN F8R1E3_HUMAN G1EMZ5_HUMAN E9NVG8_HUMAN E1U683_HUMAN C9E1J2_HUMAN J7K1D9_HUMAN G1EN10_HUMAN A7X5C2_HUMAN F1CCQ9_HUMAN D7GK32_HUMAN F2X662_HUMAN Q8SNC3_HUMAN F2VNV0_HUMAN D7NSS9_HUMAN D2KZY2_HUMAN G0WVD8_HUMAN C8CJD4_HUMAN A5YVG9_HUMAN Q30104_HUMAN I6M557_HUMAN Q7JGS8_HUMAN G9F9T7_HUMAN C8XTN0_HUMAN F4NBL8_HUMAN J9PWW5_HUMAN Q6PYB1_HUMAN Q9BCT6_HUMAN G8GIE7_HUMAN Q29632_HUMAN F1CCQ8_HUMAN F8R1E4_HUMAN D5FID8_HUMAN D7RIH0_HUMAN F2X654_HUMAN J7FM92_HUMAN G9HTG4_HUMAN Q9BCS5_HUMAN G0WVD6_HUMAN Q30008_HUMAN B2ZCY0_HUMAN D3KYL3_HUMAN G8GB37_HUMAN D7RIG7_HUMAN Q9UIM7_HUMAN Q5Y7B6_HUMAN E2GJN8_HUMAN Q29671_HUMAN L0BXK6_HUMAN F4NBL7_HUMAN H8WV94_HUMAN Q29692_HUMAN Q56FN7_HUMAN Q45KF7_HUMAN F2VP95_HUMAN Q95IF1_HUMAN J7K1E4_HUMAN H8WV96_HUMAN G1EMY8_HUMAN Q9MY65_HUMAN Q861G1_HUMAN D5FZP2_HUMAN Q860C0_HUMAN I0J8R2_HUMAN G9HWB9_HUMAN E1V2K2_HUMAN Q9BCS6_HUMAN F2VNU9_HUMAN Q5FY46_HUMAN F6KS25_HUMAN E2GJN7_HUMAN H8WV84_HUMAN Q9GJG1_HUMAN H8WUJ3_HUMAN D9U3H9_HUMAN C9WEW6_HUMAN F4NBM3_HUMAN Q8HWN1_HUMAN D0VE59_HUMAN G0ZDX3_HUMAN D6BPR4_HUMAN G4XPM2_HUMAN O19791_HUMAN E9NVF8_HUMAN E1V2J4_HUMAN Q861B0_HUMAN E1Y6P7_HUMAN G5EM95_HUMAN F4YZW5_HUMAN C9W8B4_HUMAN F1CCQ4_HUMAN B5B9V7_HUMAN E7BYE0_HUMAN H2BDT5_HUMAN C8XTJ7_HUMAN D6MJL3_HUMAN Q768U3_HUMAN Q9UM36_HUMAN F8RHJ6_HUMAN C0MP09_HUMAN Q860I8_HUMAN Q29696_HUMAN D9IFR2_HUMAN D2D3I3_HUMAN E8ZWG7_HUMAN A0AQY1_HUMAN D7RIG0_HUMAN I1SB23_HUMAN C6GZ76_HUMAN Q5NDA2_HUMAN D9UAX3_HUMAN E1V2J8_HUMAN Q9MYD9_HUMAN Q9BCN3_HUMAN O46873_HUMAN H6VQN9_HUMAN A0N0W3_HUMAN F1CCN3_HUMAN D9IFR0_HUMAN D2D3H3_HUMAN Q31644_HUMAN I7CE35_HUMAN Q14FK6_HUMAN J7F697_HUMAN D6PZZ5_HUMAN I7KLY6_HUMAN Q9TQ78_HUMAN Q5Y7E0_HUMAN B3GV29_HUMAN Q860E3_HUMAN E7D850_HUMAN D7RIH4_HUMAN B2G3E5_HUMAN C0MQV9_HUMAN F8RHM9_HUMAN C8CJC8_HUMAN Q7YQA2_HUMAN Q7YQ30_HUMAN F8RHM7_HUMAN Q9BD02_HUMAN B3VTQ8_HUMAN H8WV77_HUMAN A2BFX2_HUMAN J7F7B7_HUMAN E5RV98_HUMAN Q8MGY3_HUMAN F8RHN0_HUMAN H8WV93_HUMAN I6NVR2_HUMAN F5CSM5_HUMAN F1CCN7_HUMAN O77962_HUMAN Q9GIX0_HUMAN E3SWP3_HUMAN B3V8R6_HUMAN J7JXR5_HUMAN F2X657_HUMAN F2VNW3_HUMAN Q860E6_HUMAN C0LAB6_HUMAN Q9TQ48_HUMAN D7GN75_HUMAN O19735_HUMAN I6TN34_HUMAN E3SWQ2_HUMAN 2B13_HUMAN A7UP04_HUMAN B1VJP6_HUMAN D6PZY9_HUMAN A5HMQ3_HUMAN C8XTM0_HUMAN I6NN61_HUMAN C7FDW8_HUMAN Q8MHQ0_HUMAN I6NWK5_HUMAN F8R1E7_HUMAN O46870_HUMAN F1CCQ0_HUMAN F8RHL9_HUMAN Q7YPW3_HUMAN E2D5U3_HUMAN C8XTK9_HUMAN F2X668_HUMAN Q5Y7C2_HUMAN E2GJN6_HUMAN F8R8M6_HUMAN J7K7H4_HUMAN D5FIE7_HUMAN F8SY59_HUMAN Q702H0_HUMAN H8WV82_HUMAN E3SWP8_HUMAN Q9UM34_HUMAN O19621_HUMAN G9HRQ3_HUMAN C4PFX4_HUMAN A7UHF9_HUMAN D3U4E6_HUMAN Q6S5I0_HUMAN Q2LIR5_HUMAN Q29649_HUMAN Q860S8_HUMAN J7K483_HUMAN D3JV10_HUMAN D3U4E4_HUMAN C6H0Y3_HUMAN Q8SP68_HUMAN A4URM3_HUMAN F4YUA7_HUMAN A0AQZ0_HUMAN Q19K82_HUMAN K4RIC6_HUMAN Q5ID26_HUMAN Q3LAG4_HUMAN G8GB41_HUMAN D3GN37_HUMAN Q0PH71_HUMAN H8WV86_HUMAN B1GVZ9_HUMAN Q9GJG2_HUMAN F4NBN6_HUMAN D5FUG6_HUMAN B2ZCX8_HUMAN D2D3H2_HUMAN Q30195_HUMAN C9DA77_HUMAN Q9MYA0_HUMAN D5FID2_HUMAN Q3LAA5_HUMAN Q31639_HUMAN K0PBG7_HUMAN Q5Y7C5_HUMAN H8WV88_HUMAN B2RG89_HUMAN Q95IT4_HUMAN G8B1X6_HUMAN C7FDW7_HUMAN Q3LTJ4_HUMAN Q30105_HUMAN F1AQS1_HUMAN C9WEV5_HUMAN I7D962_HUMAN H8WV59_HUMAN D7NR19_HUMAN L0BVN9_HUMAN H9AB26_HUMAN Q8HWS6_HUMAN D5L9F2_HUMAN C9WEX7_HUMAN Q6RCP7_HUMAN Q2L4U2_HUMAN D0VE58_HUMAN Q56FN6_HUMAN Q56FN5_HUMAN K0P0J3_HUMAN C8XTL4_HUMAN Q14FK7_HUMAN Q53ZR8_HUMAN F4NBM0_HUMAN E2GJN5_HUMAN D9UAX4_HUMAN D0VE51_HUMAN Q30179_HUMAN D7GN77_HUMAN F2VPA1_HUMAN C6L826_HUMAN C5E7P3_HUMAN G1EMZ1_HUMAN E3SWP9_HUMAN D7NPQ5_HUMAN Q9BD35_HUMAN Q202I5_HUMAN D0VE48_HUMAN Q7YQ99_HUMAN Q06653_HUMAN G1CD91_HUMAN Q9TPB7_HUMAN D9U3I1_HUMAN F1CCP6_HUMAN C8XTK5_HUMAN Q6BDC5_HUMAN Q3LAB4_HUMAN F8R8N2_HUMAN F4NBK9_HUMAN A7UMH1_HUMAN Q9TQ54_HUMAN K7WK01_HUMAN Q95IE4_HUMAN D3JV13_HUMAN C1KJK6_HUMAN H8WV67_HUMAN E0X9N0_HUMAN D7RIH2_HUMAN B5QSK7_HUMAN Q56FN4_HUMAN D5FIE2_HUMAN H8WV70_HUMAN C8XTM5_HUMAN C9WEX0_HUMAN F4NBL9_HUMAN G1EGZ7_HUMAN B9WPM8_HUMAN D6CJD7_HUMAN D9U3I2_HUMAN Q95IE2_HUMAN F8RHN1_HUMAN Q95HK5_HUMAN D7RJ37_HUMAN C9WEX5_HUMAN C9E1J3_HUMAN Q7YQ32_HUMAN D2K7S1_HUMAN O62887_HUMAN H9C8X6_HUMAN E3SGD6_HUMAN H8WV74_HUMAN Q860E1_HUMAN Q7YQA7_HUMAN B3VTQ4_HUMAN Q9GIY6_HUMAN E3SWR0_HUMAN D5FZP6_HUMAN C8XTJ8_HUMAN Q9BD12_HUMAN Q19K81_HUMAN G9HRM5_HUMAN H8WV60_HUMAN I7JI15_HUMAN H8WV78_HUMAN C8XTK6_HUMAN Q861G4_HUMAN C8XTI7_HUMAN F8RHL8_HUMAN A7UHG8_HUMAN Q9TQ63_HUMAN Q30130_HUMAN E2D5U5_HUMAN Q29736_HUMAN F8SY60_HUMAN F1CCP8_HUMAN A7UNZ9_HUMAN D3K479_HUMAN C9WEV9_HUMAN Q19K84_HUMAN O19517_HUMAN H8WV66_HUMAN O02951_HUMAN E2GJN4_HUMAN E2DHC1_HUMAN F4NBM5_HUMAN Q4PRC4_HUMAN Q6UB42_HUMAN A7X5F9_HUMAN E9NVH5_HUMAN E1U685_HUMAN F8RHK1_HUMAN F1CCQ1_HUMAN J7RFS4_HUMAN A7UNZ7_HUMAN I7DEM0_HUMAN G1EMY5_HUMAN Q7YQ27_HUMAN F8RHK5_HUMAN D6MJL1_HUMAN H8WV98_HUMAN E2DHC3_HUMAN C7FDW5_HUMAN C8CJD6_HUMAN G8G268_HUMAN B3KYW3_HUMAN I6NN89_HUMAN H9BSP6_HUMAN Q3LAA9_HUMAN Q3LTJ3_HUMAN B2NJ34_HUMAN A8D305_HUMAN O19786_HUMAN H0Y4M2_HUMAN C8C9V7_HUMAN F4NBL3_HUMAN B2NJ39_HUMAN O78037_HUMAN Q9GIL4_HUMAN B0RZ68_HUMAN E5D6L7_HUMAN D2D3I0_HUMAN F2X653_HUMAN Q30106_HUMAN C0MP08_HUMAN F2VPA3_HUMAN D2D3H7_HUMAN C9E1J1_HUMAN F2VNV9_HUMAN D7NP76_HUMAN D7GN74_HUMAN C9WEW7_HUMAN G1DUW3_HUMAN G1EMZ3_HUMAN D2D3H0_HUMAN G0X8V1_HUMAN L0RH33_HUMAN B7U794_HUMAN O19547_HUMAN F6KS24_HUMAN Q2PBC3_HUMAN E9NVH6_HUMAN D5M8A1_HUMAN C9WEW5_HUMAN A0AQZ2_HUMAN B2NJ33_HUMAN J7F669_HUMAN I7APH6_HUMAN H2BDR6_HUMAN A7X5C9_HUMAN F8TVY1_HUMAN F1CCN8_HUMAN F8SL06_HUMAN B5A8Y7_HUMAN Q861G5_HUMAN D0EV56_HUMAN A8D9Y3_HUMAN D0VE47_HUMAN H6ULF5_HUMAN F8RHL2_HUMAN Q30109_HUMAN C5J434_HUMAN A8D9Z3_HUMAN E3SGC9_HUMAN D2U823_HUMAN O19586_HUMAN Q30139_HUMAN E3SWQ5_HUMAN H2BDS5_HUMAN G0X8U7_HUMAN D3Y5Y1_HUMAN G0WVE1_HUMAN Q2A128_HUMAN Q9BCS8_HUMAN Q95HN0_HUMAN C8CJD1_HUMAN G1EMZ7_HUMAN C7C5G1_HUMAN Q3LAB5_HUMAN G0WJF4_HUMAN D5M8A2_HUMAN F2X661_HUMAN C8XTM7_HUMAN Q8HWG3_HUMAN Q4JH26_HUMAN F8STB1_HUMAN C5NU45_HUMAN Q45G73_HUMAN B6DST2_HUMAN Q29796_HUMAN F1CCM2_HUMAN Q9MY46_HUMAN C9WEY3_HUMAN C8XTI9_HUMAN Q3LTJ1_HUMAN H8WV62_HUMAN Q9TQ45_HUMAN Q0PGS7_HUMAN E9NVH1_HUMAN E5RV91_HUMAN E1V2K0_HUMAN G8GB40_HUMAN D2D3G5_HUMAN Q4A1G9_HUMAN H2BDS6_HUMAN G1EN17_HUMAN Q9GJE9_HUMAN Q30111_HUMAN C0LAC0_HUMAN Q4U4M6_HUMAN A0T4C3_HUMAN D5FID1_HUMAN L0BXQ5_HUMAN D5M8A4_HUMAN Q860I3_HUMAN A8CKH4_HUMAN Q6DMR0_HUMAN H6A2E8_HUMAN D5FIE6_HUMAN C8C9V4_HUMAN G9HRQ0_HUMAN F8RHK8_HUMAN Q9MYC2_HUMAN I1V1W8_HUMAN B3GDG8_HUMAN A8KQQ2_HUMAN E9NVH4_HUMAN F2VP96_HUMAN F4NBN8_HUMAN B3VTQ2_HUMAN Q95IF0_HUMAN Q1G0Z7_HUMAN L8BTX7_HUMAN Q9TQ61_HUMAN G9I2P7_HUMAN G0X8U8_HUMAN F1CCM1_HUMAN G0ZPP3_HUMAN Q5IFG9_HUMAN F6KS30_HUMAN C9WEX2_HUMAN Q860S7_HUMAN G1EMZ2_HUMAN F4NBN2_HUMAN C8CJC9_HUMAN D3UT98_HUMAN H9AWW8_HUMAN D3U4E9_HUMAN Q30128_HUMAN A9YTA3_HUMAN C7FDW9_HUMAN C8C9V9_HUMAN D7GN76_HUMAN D5L9E7_HUMAN B5A8Y5_HUMAN A7UMH6_HUMAN H2BDS3_HUMAN D9UC11_HUMAN B2RG88_HUMAN D9U3H8_HUMAN E2DHB9_HUMAN G9HRM6_HUMAN Q0R326_HUMAN C8XTK1_HUMAN Q8HWN3_HUMAN K4Q1G1_HUMAN C0LAB8_HUMAN C8C9V5_HUMAN G8HT86_HUMAN F4YUA6_HUMAN F2X650_HUMAN D2EAF6_HUMAN A7UP02_HUMAN C8XTL0_HUMAN C9WEX9_HUMAN J7GUA3_HUMAN J7F4Z7_HUMAN A0N9E2_HUMAN G9HRM3_HUMAN F8R1E8_HUMAN D5G2K9_HUMAN E0X9M9_HUMAN E7BYE1_HUMAN D5FZP1_HUMAN G9FJI0_HUMAN A8WDP0_HUMAN F1CCM8_HUMAN F8VZH6_HUMAN H8WV83_HUMAN F6KS28_HUMAN Q95IH1_HUMAN Q860S2_HUMAN J9PWN0_HUMAN D5FIF1_HUMAN F1CCM5_HUMAN F8SL11_HUMAN Q3LTK0_HUMAN A4VAP8_HUMAN F6KS29_HUMAN G0Z6Y8_HUMAN Q860V5_HUMAN F8RHJ1_HUMAN C6L828_HUMAN D2D3H5_HUMAN Q5NT90_HUMAN G4XPM1_HUMAN D5FUG4_HUMAN F4NBN4_HUMAN Q29646_HUMAN D6BPR3_HUMAN E1U687_HUMAN F4NBL1_HUMAN C9WEW3_HUMAN D2D3H4_HUMAN B6ETP3_HUMAN E9NVH3_HUMAN Q8HWN4_HUMAN K7XHD2_HUMAN Q70IU8_HUMAN K0P793_HUMAN Q9TQ83_HUMAN G5EM91_HUMAN A5YP91_HUMAN D5G249_HUMAN E3SWQ3_HUMAN Q95HK6_HUMAN H2DML4_HUMAN C9WEV4_HUMAN G0ZMN0_HUMAN D7RIG6_HUMAN F8RHL3_HUMAN Q3LAA3_HUMAN B8YM95_HUMAN C1JJS3_HUMAN Q9BD26_HUMAN C8XTK8_HUMAN Q861H9_HUMAN Q9Y4H8_HUMAN H6A2E7_HUMAN G8HT88_HUMAN Q6T714_HUMAN L0BXM6_HUMAN G1EN04_HUMAN Q9UEX9_HUMAN A1Z0K9_HUMAN G1EMV6_HUMAN B9WPM3_HUMAN D3U4E3_HUMAN D5L9E9_HUMAN Q9TPW2_HUMAN F4NBL2_HUMAN D3JV17_HUMAN D5FUG1_HUMAN G9HRM9_HUMAN Q9TQ55_HUMAN F2X664_HUMAN E5D6L8_HUMAN F4YZX3_HUMAN Q861G3_HUMAN Q4F6M6_HUMAN G1EMV8_HUMAN L0BXN7_HUMAN H8WV91_HUMAN B0F9M7_HUMAN C9WEY4_HUMAN E5RV96_HUMAN H9C8Y0_HUMAN D6PZZ4_HUMAN D2D3H1_HUMAN D0V3Q2_HUMAN F2QL89_HUMAN L7UUQ7_HUMAN G9I2P6_HUMAN C0MQV5_HUMAN L0BVT0_HUMAN Q3LAB2_HUMAN F2VP98_HUMAN Q0GB79_HUMAN F8RHK6_HUMAN D5FID6_HUMAN Q6WIG7_HUMAN E2D5U2_HUMAN G1EN20_HUMAN B9WPM2_HUMAN D6CJD0_HUMAN F8SYK7_HUMAN G9HRM8_HUMAN G5EM93_HUMAN K7ZK48_HUMAN I6NWK1_HUMAN D7GN79_HUMAN Q29918_HUMAN Q45G74_HUMAN A0AQX9_HUMAN F1CCM3_HUMAN G9HWB7_HUMAN I6MHJ7_HUMAN Q8HWG4_HUMAN E2GJP0_HUMAN B3CL08_HUMAN Q30103_HUMAN G9F9T9_HUMAN D2D3H8_HUMAN J7F573_HUMAN C8CJD5_HUMAN C9WEX6_HUMAN E5RV95_HUMAN A5HKN7_HUMAN D7GK31_HUMAN D0VE34_HUMAN A0AQZ1_HUMAN Q31641_HUMAN B2NJ28_HUMAN C4PJL5_HUMAN E0WN74_HUMAN Q9TQ59_HUMAN Q9TQ49_HUMAN E7BYD7_HUMAN F8RHM5_HUMAN Q56FN8_HUMAN K7ZN81_HUMAN F8RHK2_HUMAN Q9TQ58_HUMAN A2VBX3_HUMAN F4NBK8_HUMAN F1CCP4_HUMAN F8R8M3_HUMAN B6ZLV2_HUMAN E3SWR1_HUMAN D0VE57_HUMAN E0YNM0_HUMAN E0YTP3_HUMAN D9IFQ9_HUMAN E9NVF9_HUMAN C4R9G8_HUMAN E3SGD3_HUMAN E5D6L9_HUMAN G0Z8F9_HUMAN K4IT57_HUMAN B9WPM1_HUMAN G9I1P7_HUMAN H8WV79_HUMAN C8ZL76_HUMAN F2VNV7_HUMAN G0Z8G1_HUMAN E0X9M8_HUMAN I6YAZ4_HUMAN D2D3I2_HUMAN D7GL10_HUMAN F2VP97_HUMAN F4YZW7_HUMAN Q9GJ28_HUMAN Q8HWS9_HUMAN H2AM04_HUMAN A7UP01_HUMAN L7QJG9_HUMAN D5FID3_HUMAN Q0VUQ9_HUMAN C9DA78_HUMAN Q7YPZ4_HUMAN I6NXH9_HUMAN A0AQY4_HUMAN B2NJ36_HUMAN Q9BCP9_HUMAN A7UNZ6_HUMAN B1VK37_HUMAN D1G119_HUMAN F1AQS3_HUMAN G9HRQ2_HUMAN G1EN19_HUMAN F2VS02_HUMAN D7NPQ6_HUMAN C6L827_HUMAN C5NU25_HUMAN B9WPM6_HUMAN Q860I1_HUMAN O19732_HUMAN L0BVZ5_HUMAN G9HRN3_HUMAN Q9GJ59_HUMAN Q7YQ35_HUMAN A7UHG4_HUMAN G8GJC3_HUMAN D3JV08_HUMAN G0ZDX4_HUMAN L0BXL7_HUMAN Q5JZX3_HUMAN J7QWX7_HUMAN G1EN00_HUMAN F2VNW6_HUMAN Q29687_HUMAN F8SL04_HUMAN F1AQS2_HUMAN F2VNW8_HUMAN F8RHL4_HUMAN A0AQZ3_HUMAN D2DL42_HUMAN Q8WLR9_HUMAN F4NBK6_HUMAN Q3LA85_HUMAN F8RHK9_HUMAN Q5DUF5_HUMAN G9HW14_HUMAN A1A417_HUMAN A1A416_HUMAN Q9TQE1_HUMAN Q8MGY6_HUMAN 2B1C_HUMAN O62890_HUMAN H8WV63_HUMAN F8RHK0_HUMAN Q9TQD9_HUMAN A5I885_HUMAN Q29668_HUMAN G8HT84_HUMAN G9DBH3_HUMAN D3U4F3_HUMAN D6MKY5_HUMAN F4YZW6_HUMAN Q29735_HUMAN G8HT87_HUMAN E0YNM2_HUMAN D0VE50_HUMAN C5E7P4_HUMAN F8RHM0_HUMAN F2X652_HUMAN F8R1E5_HUMAN F1CCL7_HUMAN D6PZZ3_HUMAN G0ZDX2_HUMAN E7CYG1_HUMAN F8SY61_HUMAN Q15BP8_HUMAN K0P7G6_HUMAN C8CHC5_HUMAN D7RIH9_HUMAN E3SGD0_HUMAN F4NBM4_HUMAN Q9TP92_HUMAN E9BVU5_HUMAN L0BX34_HUMAN D9IFR3_HUMAN E3SWQ9_HUMAN Q19A33_HUMAN A8YQE8_HUMAN E0WMV6_HUMAN H8WV56_HUMAN A8D9Y6_HUMAN F1CCR1_HUMAN G0X8U9_HUMAN D7GN78_HUMAN F4NBN1_HUMAN Q2HPT8_HUMAN G1EN18_HUMAN D7RIH8_HUMAN Q7YPZ9_HUMAN A9Z190_HUMAN C8XTK2_HUMAN C8XTM6_HUMAN Q3LAB9_HUMAN D2K7S2_HUMAN G9FJH8_HUMAN L0HNE6_HUMAN H8WV71_HUMAN L0BVR7_HUMAN D2D3G7_HUMAN A0PFK3_HUMAN H2BDT2_HUMAN E3SWQ8_HUMAN K0DF01_HUMAN D6MKY6_HUMAN L0HR21_HUMAN D5FZP3_HUMAN G9HRM4_HUMAN Q9BCM3_HUMAN 2B19_HUMAN D3U4F1_HUMAN D5L9F3_HUMAN B7VU65_HUMAN Q9TQ60_HUMAN Q860T0_HUMAN G9I2P5_HUMAN L0BVZ3_HUMAN D5L9F4_HUMAN Q9BCP7_HUMAN H8WV58_HUMAN B5A8Y6_HUMAN C8CJC7_HUMAN D0FI72_HUMAN Q861B8_HUMAN Q9TP96_HUMAN Q5Y7G6_HUMAN F8RHJ0_HUMAN Q95HK7_HUMAN Q6WIG6_HUMAN B9WPM4_HUMAN A0AQY8_HUMAN G1EN16_HUMAN Q30107_HUMAN G8GB36_HUMAN A7X5G4_HUMAN F1CCP0_HUMAN O19592_HUMAN B3VTQ5_HUMAN H2DLU4_HUMAN D0RB87_HUMAN Q9MYG3_HUMAN Q9GJF7_HUMAN A7UHG1_HUMAN O78184_HUMAN F1CCM7_HUMAN H8WV97_HUMAN C5IAX3_HUMAN A7UP10_HUMAN G0WVD7_HUMAN F8RHM1_HUMAN Q9BCP6_HUMAN I7CHF2_HUMAN E2D5U6_HUMAN Q9TQ64_HUMAN D3JV39_HUMAN F4YUA5_HUMAN Q7YP63_HUMAN Q860Y8_HUMAN B2NJ37_HUMAN E9NVH2_HUMAN Q9MY77_HUMAN G8G269_HUMAN Q29723_HUMAN G3CC12_HUMAN C6H0J8_HUMAN G9FJH7_HUMAN F2X670_HUMAN J7F8N2_HUMAN Q9BCP8_HUMAN C8XTJ3_HUMAN Q2PZR1_HUMAN Q29754_HUMAN Q5CC31_HUMAN F4YZX2_HUMAN F8RHJ8_HUMAN Q9MYD7_HUMAN O95729_HUMAN C6L819_HUMAN D7NPQ4_HUMAN Q8WLS0_HUMAN 2B1F_HUMAN E1U684_HUMAN Q7YQA6_HUMAN E2D5U8_HUMAN F8LSY0_HUMAN H2E2A8_HUMAN B2CR04_HUMAN E7BYD6_HUMAN E5RV99_HUMAN F2X667_HUMAN B3V8R5_HUMAN C8CJA6_HUMAN F4NBN7_HUMAN J7FP09_HUMAN Q861C6_HUMAN G3LZX8_HUMAN G0Z8G0_HUMAN B2NJ35_HUMAN D5FIE4_HUMAN Q9TQ47_HUMAN C8XTL3_HUMAN O19738_HUMAN B2ZCX9_HUMAN F1CCQ2_HUMAN Q95HN2_HUMAN E1V2K1_HUMAN G0X8U6_HUMAN G1EMZ9_HUMAN Q3LAC1_HUMAN A7UHG3_HUMAN E3SGD5_HUMAN Q3LAB0_HUMAN F8SY56_HUMAN C8XTJ2_HUMAN J7F672_HUMAN L0HRH2_HUMAN F8RHL6_HUMAN K0P7G9_HUMAN F8RHM8_HUMAN F2VPA4_HUMAN H6A2E9_HUMAN G0WVD9_HUMAN Q9TP94_HUMAN D2D3G9_HUMAN D2D3H9_HUMAN D7GK33_HUMAN Q6BDC8_HUMAN G1EN13_HUMAN C4PJL6_HUMAN B5BLW4_HUMAN F6KS26_HUMAN A1A415_HUMAN F4NBN5_HUMAN G1EN05_HUMAN Q58HT8_HUMAN Q9BD24_HUMAN F2VNV2_HUMAN D2D3H6_HUMAN E0WN75_HUMAN C4RA90_HUMAN D7RIH3_HUMAN D7R0V1_HUMAN G9HWB8_HUMAN C8CJD9_HUMAN E7EI14_HUMAN A5HED9_HUMAN A7UMH4_HUMAN F2RM38_HUMAN F2VPA2_HUMAN L7SW87_HUMAN H2AM03_HUMAN D5FID4_HUMAN Q75NJ4_HUMAN Q30136_HUMAN Q30132_HUMAN G1EMY9_HUMAN Q9TQ41_HUMAN Q3LAA7_HUMAN G5EM94_HUMAN B3VTQ1_HUMAN Q6S5H9_HUMAN F8SY62_HUMAN F4YUA9_HUMAN C9E1J4_HUMAN H8WV72_HUMAN B3VTQ7_HUMAN C8CHC6_HUMAN B8Y6B1_HUMAN Q1KLJ9_HUMAN Q95HK3_HUMAN E2GJP1_HUMAN Q9MY91_HUMAN C0MNB7_HUMAN H2BDS0_HUMAN D5G251_HUMAN L0BVW9_HUMAN A5JNG9_HUMAN C8XTK3_HUMAN C8CHC3_HUMAN C8C9W1_HUMAN E2D5U7_HUMAN F4NBK5_HUMAN Q9TQ52_HUMAN Q5EGD8_HUMAN J9PVC6_HUMAN F8R8M4_HUMAN D5FIF0_HUMAN C7FDX0_HUMAN G1EN01_HUMAN J7K3J3_HUMAN Q3LAA8_HUMAN A7X5K1_HUMAN A7UP00_HUMAN Q56FP5_HUMAN A0AQX8_HUMAN C9DSL5_HUMAN D7RIG5_HUMAN E3Q0T3_HUMAN Q9GIY9_HUMAN A1Z1P0_HUMAN D3JV14_HUMAN Q2LIR3_HUMAN H8WV65_HUMAN F8RHM4_HUMAN Q70Q10_HUMAN F8RHN3_HUMAN C9WEX8_HUMAN B0LUY9_HUMAN H2BDT0_HUMAN Q861G2_HUMAN B8Y6B0_HUMAN D0EVN8_HUMAN Q9TP97_HUMAN B3GDG7_HUMAN G9HWB5_HUMAN F1CCM0_HUMAN O19587_HUMAN D2U824_HUMAN Q9TQ44_HUMAN F4YZX1_HUMAN Q75NJ5_HUMAN Q6T862_HUMAN Q860E4_HUMAN B7VF70_HUMAN D5L9F5_HUMAN C5J8E6_HUMAN F2VNW4_HUMAN D5FZN9_HUMAN F4YZX0_HUMAN Q95384_HUMAN G1EN06_HUMAN Q95HN3_HUMAN H2BDS1_HUMAN F6KS21_HUMAN Q8SP67_HUMAN Q8SND0_HUMAN B0L892_HUMAN Q45W57_HUMAN D1GZJ1_HUMAN Q4ZJJ2_HUMAN B2NJ32_HUMAN B6E315_HUMAN F1CCQ7_HUMAN G9HW10_HUMAN A7UMH3_HUMAN E3Q0T2_HUMAN H2BDT4_HUMAN G9HRN2_HUMAN G1EMZ6_HUMAN Q9MYA1_HUMAN D3U4E5_HUMAN D5FZP8_HUMAN Q860Y4_HUMAN D3JV15_HUMAN D5M8A3_HUMAN D5FUG8_HUMAN F8SL07_HUMAN Q30009_HUMAN Q2LDE4_HUMAN H8WV89_HUMAN C8CJD2_HUMAN C3VJ06_HUMAN Q4A1S0_HUMAN F8URE1_HUMAN D3JV12_HUMAN F8SY57_HUMAN C5MRD8_HUMAN B0LUU5_HUMAN G0X8V0_HUMAN D5L9F1_HUMAN H8WV81_HUMAN Q861A5_HUMAN A0AQY7_HUMAN Q9XRW9_HUMAN F2X362_HUMAN Q9UQT8_HUMAN Q45G75_HUMAN H2A3P4_HUMAN E0WN72_HUMAN Q30113_HUMAN E0YTP4_HUMAN C7EX09_HUMAN G0ZMN1_HUMAN Q9TQ23_HUMAN Q9BD07_HUMAN G1EN11_HUMAN G1EMV7_HUMAN G5EM92_HUMAN C6L822_HUMAN C8XTM9_HUMAN Q31642_HUMAN E3SWQ4_HUMAN L0BWW8_HUMAN Q9BCM2_HUMAN O19736_HUMAN H8WV80_HUMAN D3U4E7_HUMAN F8VZR1_HUMAN D5KXD1_HUMAN D7GL11_HUMAN B3V8R4_HUMAN B3GV31_HUMAN Q8WMA1_HUMAN A3RM26_HUMAN C8XTK0_HUMAN E5RV92_HUMAN C9WEW0_HUMAN B3VTQ6_HUMAN Q7YPZ8_HUMAN I6Z8F2_HUMAN D5FIE8_HUMAN Q6T718_HUMAN G8GB39_HUMAN D5FUG3_HUMAN O78080_HUMAN J7F8K6_HUMAN A6YQP1_HUMAN F4YZW8_HUMAN F8RHI9_HUMAN Q29711_HUMAN H8WV64_HUMAN G9HRN1_HUMAN A0N0W5_HUMAN Q3LAC3_HUMAN A5PHT3_HUMAN Q9BD34_HUMAN Q5GMP5_HUMAN Q5Y7G9_HUMAN Q29887_HUMAN D5FIE5_HUMAN Q29647_HUMAN F4NBM6_HUMAN E2D5U4_HUMAN G0Z6Y7_HUMAN O62880_HUMAN Q861H6_HUMAN F8SY58_HUMAN Q9BD27_HUMAN Q1EIR2_HUMAN E3SWQ1_HUMAN F8VX19_HUMAN Q9GIX7_HUMAN F5BR66_HUMAN G0LXY7_HUMAN Q5XWD6_HUMAN D3UTA6_HUMAN H2BDS9_HUMAN F2X0U6_HUMAN F4NBM9_HUMAN B8ZHC3_HUMAN H8WV68_HUMAN O77978_HUMAN D0VE49_HUMAN A6MWD7_HUMAN F4NBN9_HUMAN K4REA4_HUMAN O19622_HUMAN C8XTJ6_HUMAN C5NU26_HUMAN A7UHG9_HUMAN L0BVP2_HUMAN G9FZ59_HUMAN Q9TQ46_HUMAN B6ETR7_HUMAN A0AQY2_HUMAN F5A501_HUMAN E2DHC2_HUMAN Q860S1_HUMAN C7FDW6_HUMAN E0WN73_HUMAN A4F5N1_HUMAN F8RHL1_HUMAN Q95IG7_HUMAN J7F582_HUMAN Q30158_HUMAN G1EMY7_HUMAN F1CCP3_HUMAN Q19K83_HUMAN E2D5U9_HUMAN F8RHK3_HUMAN Q8HWL8_HUMAN E2DHC0_HUMAN B3VTQ0_HUMAN O19594_HUMAN E5RVA1_HUMAN G0WVD5_HUMAN C8XTM4_HUMAN C8CJD8_HUMAN F1CT76_HUMAN D7R0W0_HUMAN Q3LAB8_HUMAN Q9TQ39_HUMAN E9NVG4_HUMAN G8GLM3_HUMAN G4VU14_HUMAN E3WHS7_HUMAN E1V2J6_HUMAN G9HWB4_HUMAN D2D3G4_HUMAN F1CCP2_HUMAN L0TE80_HUMAN A3RM25_HUMAN Q5DKQ6_HUMAN A4UUM5_HUMAN F6KS31_HUMAN K4RID0_HUMAN A7UMH7_HUMAN B7TXX6_HUMAN A7XFV9_HUMAN D5FZP7_HUMAN F4NBN0_HUMAN Q8HWT8_HUMAN F4NBK7_HUMAN A9YQ96_HUMAN D5FZN8_HUMAN F2VNW7_HUMAN Q95386_HUMAN Q29737_HUMAN D2D3G6_HUMAN Q861H3_HUMAN Q8SNC2_HUMAN G1EMY6_HUMAN A7UHG5_HUMAN C7DRS1_HUMAN D7RIH5_HUMAN Q3LAC0_HUMAN H2BDR5_HUMAN D5G250_HUMAN Q8MGZ9_HUMAN C9WEV7_HUMAN Q56FP7_HUMAN I7JCR9_HUMAN Q07122_HUMAN D2SSL7_HUMAN D0VE45_HUMAN Q9TPW8_HUMAN Q9BCQ2_HUMAN G9HRQ1_HUMAN Q1G100_HUMAN Q45FY1_HUMAN Q9TQ38_HUMAN Q95465_HUMAN D2D3I1_HUMAN E2D5U1_HUMAN G9I2P8_HUMAN C8XTL1_HUMAN Q4F6M7_HUMAN G1EN08_HUMAN A1A419_HUMAN E7BYD9_HUMAN A7X5I3_HUMAN B5A8Y4_HUMAN K0P0J2_HUMAN A0AQY3_HUMAN C9WEY0_HUMAN F8RHL7_HUMAN Q06RK2_HUMAN O98047_HUMAN H8WV61_HUMAN F8RHL0_HUMAN L0HR08_HUMAN G1EMV9_HUMAN Q29651_HUMAN D0VE55_HUMAN C0MQC3_HUMAN L0BVW1_HUMAN Q1G0Z8_HUMAN C9WEV8_HUMAN C8C9W2_HUMAN Q6T717_HUMAN H2BDT3_HUMAN H8WV69_HUMAN F8RHJ5_HUMAN Q9TPX0_HUMAN I6NWM5_HUMAN C0MP10_HUMAN G9HWB3_HUMAN D0VE54_HUMAN C8XTJ4_HUMAN I6ZTP2_HUMAN 2B14_HUMAN Q95IE6_HUMAN A7DWG6_HUMAN Q860B8_HUMAN H8WV92_HUMAN B9WPM7_HUMAN D7RIH6_HUMAN Q5U8S4_HUMAN Q7YQA4_HUMAN A1DS51_HUMAN Q29732_HUMAN A7UP06_HUMAN D9UAX2_HUMAN F2VNW0_HUMAN A7UMH2_HUMAN F2VS07_HUMAN Q9TQ51_HUMAN Q30133_HUMAN C9WEW8_HUMAN F2VNV1_HUMAN H2E2A7_HUMAN Q6Y1S2_HUMAN H2BDS8_HUMAN D3Y5Y3_HUMAN A3FP43_HUMAN F2X666_HUMAN Q3LAB6_HUMAN D1G120_HUMAN (see all proteins)
(see all similar genes)(see first protein):HLA DRB4 HLA-DRB1*0402 HLA-DRB1*0407 HLA-DRB1*1301 HLA-DRB1*1302 HLA-DRB1*1402 HLA-All HLA-A null HLA-A*03 HLA-DRB13 HLA-DRB1*1605 HLA-B27 HLA-DRB1*1327 HLA-Cw3 HLA-DRB14 HLA-D8.2V HLA DRB1 HLA-DRB4$0101
HLA-DRB1 for paralogs About GeneDecksing
|
Genomic Variants for HLA-DRB1 gene(SNPs/Variants according to the
1NCBI SNP Database,
2Ensembl,
3PupaSUITE,
UniProtKB, and
DNA2.0,
Linkage Disequilibrium by HapMap,
Structural Variations(CNVs/InDels/Inversions) from the Database of Genomic Variants, Mutations from the Human Gene
Mutation Database (HGMD) and the Locus Specific Mutation
Databases (LSDB), Blood group antigen gene mutations by BGMUT,
Resequencing Primers from QIAGEN,
Cancer Mutation PCR Arrays and Assays and Copy Number PCR Arrays from SABiosciences)
About This Section
| UniProtKB/Swiss-Prot: 2B1G_HUMAN, Q29974Polymorphism: The following alleles of DRB1-1 are known: DRB1*01:01; DRB1*01:02; DRB1*01:03; DRB1*01:04; DRB1*01:05;DRB1*01:06; DRB1*01:07; DRB1*01:08; DRB1*01:09; DRB1*01:10; DRB1*01:11; DRB1*01:12; DRB1*01:13; DRB1*01:14;DRB1*01:15; DRB1*01:16; DRB1*01:17; DRB1*01:18; DRB1*01:19; DRB1*01:20 and DRB1*01:21. The sequence shown is that ofDRB1*01:01Polymorphism: The following alleles of DRB1-3 are known: DRB1*03:01; DRB1*03:02; DRB1*03:03; DRB1*03:04; DRB1*03:05;DRB1*03:06; DRB1*03:07; DRB1*03:08; DRB1*03:09; DRB1*03:10; DRB1*03:11; DRB1*03:12; DRB1*03:13; DRB1*03:14;DRB1*03:15; DRB1*03:16; DRB1*03:17; DRB1*03:18; DRB1*03:19; DRB1*03:20; DRB1*03:21; DRB1*03:22; DRB1*03:23;DRB1*03:24; DRB1*03:25; DRB1*03:26; DRB1*03:27; DRB1*03:28; DRB1*03:29; DRB1*03:30; DRB1*03:31; DRB1*03:32;DRB1*03:33; DRB1*03:34; DRB1*03:35; DRB1*03:36; DRB1*03:37; DRB1*03:38; DRB1*03:39; DRB1*03:40 and DRB1*03:41. Thesequence shown is that of DRB1*03:01Polymorphism: The following alleles of DRB1-4 are known: DRB1*04:01, DRB1*04:02, DRB1*04:03, DRB1*04:04, DRB1*04:05,DRB1*04:06, DRB1*04:07, DRB1*04:08, DRB1*04:09, DRB1*04:10, DRB1*04:11, DRB1*04:12, DRB1*04:13, DRB1*04:14,DRB1*04:15, DRB1*04:16, DRB1*04:17, DRB1*04:18, DRB1*04:19, DRB1*04:20, DRB1*04:21, DRB1*04:22, DRB1*04:23,DRB1*04:24, DRB1*04:25, DRB1*04:26, DRB1*04:27, DRB1*04:28, DRB1*04:29, DRB1*04:30, DRB1*04:31, DRB1*04:32,DRB1*04:33, DRB1*04:34, DRB1*04:35, DRB1*04:36, DRB1*04:37, DRB1*04:38, DRB1*04:39, DRB1*04:40, DRB1*04:41,DRB1*04:42, DRB1*04:43, DRB1*04:44, DRB1*04:45, DRB1*04:46, DRB1*04:47, DRB1*04:48, DRB1*04:49, DRB1*04:50,DRB1*04:51, DRB1*04:52, DRB1*04:53, DRB1*04:54, DRB1*04:55, DRB1*04:56, DRB1*04:57, DRB1*04:58, DRB1*04:59,DRB1*04:60, DRB1*04:61, DRB1*04:62, DRB1*04:63, DRB1*04:64, DRB1*04:65, DRB1*04:66, DRB1*04:67, DRB1*04:68,DRB1*04:69, DRB1*04:70, DRB1*04:71, DRB1*04:72, DRB1*04:73, DRB1*04:74, DRB1*04:75, DRB1*04:76, DRB1*04:77 andDRB1*04:78. The sequence shown is that of DRB1*04:01Polymorphism: The following alleles of DRB1-7 are known: DRB1*07:01, DRB1*07:03, DRB1*07:04, DRB1*07:05, DRB1*07:06,DRB1*07:07, DRB1*07:08, DRB1*07:09, DRB1*07:11, DRB1*07:12, DRB1*07:13, DRB1*07:14, DRB1*07:15, DRB1*07:16 andDRB1*07:17. The sequence shown is that of DRB1*07:01Polymorphism: Allele DRB1*07:01 is associated with persistent hepatitis C virus (HCV) infections [MIM:609532]Polymorphism: The following alleles of DRB1-8 are known: DRB1*08:01 (Dw8.1), DRB1*08:02 (Dw8.2; DRB1L), DRB1*08:03(Dw8.3); DRB1*08:04; DRB1*08:05, DRB1*08:06, DRB1*08:07, DRB1*08:08, DRB1*08:09, DRB1*08:10, DRB1*08:11, DRB1*08:12,DRB1*08:13, DRB1*08:14, DRB1*08:15, DRB1*08:16, DRB1*08:17, DRB1*08:18, DRB1*08:19, DRB1*08:20, DRB1*08:21,DRB1*08:22, DRB1*08:23, DRB1*08:24, DRB1*08:25, DRB1*08:26, DRB1*08:27, DRB1*08:28, DRB1*08:29, DRB1*08:30,DRB1*08:31, DRB1*08:32, DRB1*08:33, DRB1*08:34, DRB1*08:35 and DRB1*08:36. The sequence shown is that of DRB1*08:01Polymorphism: The following alleles of DRB1-9 are known: DRB1*09:01, DRB1*09:02, DRB1*09:03, DRB1*09:04, DRB1*09:05,DRB1*09:06, DRB1*09:07 and DRB1*09:08. The sequence shown is that of DRB1*09:01Polymorphism: The following alleles of DRB1-10 are known: DRB1*10:01; DRB1*10:02 and DRB1*10:03. The sequence shown isthat of DRB1*10:01Polymorphism: The following alleles of DRB1-11 are known: DRB1*11:01, DRB1*11:03, DRB1*11:04, DRB1*11:05, DRB1*11:06,DRB1*11:07, DRB1*11:08, DRB1*11:09, DRB1*11:10, DRB1*11:11, DRB1*11:12, DRB1*11:13, DRB1*11:14, DRB1*11:15,DRB1*11:16, DRB1*11:17, DRB1*11:18, DRB1*11:19, DRB1*11:20, DRB1*11:21, DRB1*11:22, DRB1*11:23, DRB1*11:24,DRB1*11:25, DRB1*11:26, DRB1*11:27, DRB1*11:28, DRB1*11:29, DRB1*11:30, DRB1*11:31, DRB1*11:32, DRB1*11:33,DRB1*11:34, DRB1*11:35, DRB1*11:36, DRB1*11:37, DRB1*11:38, DRB1*11:39, DRB1*11:40, DRB1*11:41, DRB1*11:42,DRB1*11:43, DRB1*11:44, DRB1*11:45, DRB1*11:46, DRB1*11:47, DRB1*11:48, DRB1*11:49, DRB1*11:50, DRB1*11:51,DRB1*11:52, DRB1*11:53, DRB1*11:54, DRB1*11:55, DRB1*11:56, DRB1*11:57, DRB1*11:58, DRB1*11:59, DRB1*11:60,DRB1*11:61, DRB1*11:62, DRB1*11:63, DRB1*11:64, DRB1*11:65, DRB1*11:66, DRB1*11:67, DRB1*11:68, DRB1*11:69, DRB1*11:70and DRB1*11:72. The sequence shown is that of DRB1*11:01Polymorphism: Allele DRB1*11:01 is associated with self-limiting hepatitis C virus (HCV) infections [MIM:609532]Polymorphism: The following alleles of DRB1-12 are known: DRB1*12:01, DRB1*12:02, DRB1*12:03, DRB1*12:04, DRB1*12:05,DRB1*12:06, DRB1*12:07, DRB1*12:08, DRB1*12:09, DRB1*12:10, DRB1*12:11, DRB1*12:12, DRB1*12:13, DRB1*12:14,DRB1*12:15, DRB1*12:16, DRB1*12:17, DRB1*12:18 and DRB1*12:19. The sequence shown is that of DRB1*12:01Polymorphism: The following alleles of DRB1-13 are known: DRB1*13:01, DRB1*13:02, DRB1*13:03, DRB1*13:04, DRB1*13:05,DRB1*13:06, DRB1*13:07, DRB1*13:08, DRB1*13:09, DRB1*13:10, DRB1*13:11, DRB1*13:12, DRB1*13:13, DRB1*13:14,DRB1*13:15, DRB1*13:16, DRB1*13:17, DRB1*13:18, DRB1*13:19, DRB1*13:20, DRB1*13:21, DRB1*13:22, DRB1*13:23,DRB1*13:24, DRB1*13:25, DRB1*13:26, DRB1*13:27, DRB1*13:28, DRB1*13:29, DRB1*13:30, DRB1*13:31, DRB1*13:32,DRB1*13:33, DRB1*13:34, DRB1*13:35, DRB1*13:36, DRB1*13:37, DRB1*13:38, DRB1*13:39, DRB1*13:40, DRB1*13:41,DRB1*13:42, DRB1*13:43, DRB1*13:44, DRB1*13:45, DRB1*13:46, DRB1*13:47, DRB1*13:48, DRB1*13:49, DRB1*13:50,DRB1*13:51, DRB1*13:52, DRB1*13:53, DRB1*13:54, DRB1*13:55, DRB1*13:56, DRB1*13:57, DRB1*13:58, DRB1*13:59,DRB1*13:60, DRB1*13:61, DRB1*13:62, DRB1*13:63, DRB1*13:64, DRB1*13:65, DRB1*13:66, DRB1*13:67, DRB1*13:68,DRB1*13:69, DRB1*13:70, DRB1*13:71, DRB1*13:72, DRB1*13:73, DRB1*13:74, DRB1*13:75, DRB1*13:76, DRB1*13:77,DRB1*13:78, DRB1*13:79, DRB1*13:80, DRB1*13:81, DRB1*13:82, DRB1*13:83, DRB1*13:84, DRB1*13:85, DRB1*13:86, DRB1*13:87and DRB1*13:88. The sequence shown is that of DRB1*13:01Polymorphism: The following alleles of DRB1-14 are known: DRB1*14:01, DRB1*14:02, DRB1*14:03, DRB1*14:04, DRB1*14:05,DRB1*14:06, DRB1*14:07, DRB1*14:08, DRB1*14:09, DRB1*14:10, DRB1*14:11, DRB1*14:12, DRB1*14:13, DRB1*14:14,DRB1*14:15, DRB1*14:16, DRB1*14:17, DRB1*14:18, DRB1*14:19, DRB1*14:20, DRB1*14:21, DRB1*14:22, DRB1*14:23,DRB1*14:24, DRB1*14:25, DRB1*14:26, DRB1*14:27, DRB1*14:28, DRB1*14:29, DRB1*14:30, DRB1*14:31, DRB1*14:32,DRB1*14:33, DRB1*14:34, DRB1*14:35, DRB1*14:36, DRB1*14:37, DRB1*14:38, DRB1*14:39, DRB1*14:40, DRB1*14:41,DRB1*14:42, DRB1*14:43, DRB1*14:44, DRB1*14:45, DRB1*14:46, DRB1*14:47, DRB1*14:48, DRB1*14:49, DRB1*14:50,DRB1*14:51, DRB1*14:52, DRB1*14:53, DRB1*14:54, DRB1*14:55, DRB1*14:56, DRB1*14:57, DRB1*14:58, DRB1*14:59,DRB1*14:60, DRB1*14:61, DRB1*14:62, DRB1*14:63, DRB1*14:64, DRB1*14:65, DRB1*14:67, DRB1*14:68, DRB1*14:69,DRB1*14:70, DRB1*14:71, DRB1*14:72, DRB1*14:73, DRB1*14:74, DRB1*14:75, DRB1*14:76, DRB1*14:77, DRB1*14:78,DRB1*14:79, DRB1*14:80, DRB1*14:81, DRB1*14:82, DRB1*14:83, DRB1*14:84 and DRB1*14:85. The sequence shown is that ofDRB1*14:01Polymorphism: The following alleles of DRB1-15 are known: DRB1*15:01, DRB1*15:02, DRB1*15:03, DRB1*15:04, DRB1*15:05,DRB1*15:06, DRB1*15:07, DRB1*15:08, DRB1*15:09, DRB1*15:10, DRB1*15:11, DRB1*15:12, DRB1*15:13, DRB1*15:14,DRB1*15:15, DRB1*15:16, DRB1*15:18, DRB1*15:19, DRB1*15:20, DRB1*15:21, DRB1*15:22, DRB1*15:23, DRB1*15:24,DRB1*15:25, DRB1*15:26, DRB1*15:27, DRB1*15:28, DRB1*15:29, DRB1*15:30, DRB1*15:31 and DRB1*15:32. The sequence shownis that of DRB1*15:01Polymorphism: The following alleles of DRB1-16 are known: DRB1*16:01; DRB1*16:02; DRB1*16:03; DRB1*16:04; DRB1*16:05;DRB1*16:07; DRB1*16:08; DRB1*16:09; DRB1*16:10; DRB1*16:11 and DRB1*16:12. The sequence shown is that of DRB1*16:02
| Genomic Data | Transcription Related Data | Allele Frequencies | | SNP ID | Valid | Clinical significance | Chr 6 pos | Sequence | # | AA Chg | Type | More | # | Allele freq | Pop | Total sample | More |
|---|
HapMap Linkage Disequilibrium report for HLA-DRB1 (32546546 - 32557625 bp)
Structural Variations (Copy Number Variations, Insertions/Deletions, Inversions) Database of Genomic Variants (DGV): 22 variations for HLA-DRB1 15/20 CNVs (see all 20): 7567 69436 37840 69447 69420 4767 4493 64476 3603 69431 69407 69452 81340 69421 93647 2 Indels: 33807 12831 Human Gene Mutation Database (HGMD): HLA-DRB1
Locus Specific Mutation Databases (LSDB): HLA-DRB1
 | SABiosciences Cancer Mutation PCR Assays |
|
Disorders
/ Diseases for HLA-DRB1 gene
(in which this Gene is Involved, According to MalaCards,
OMIM, UniProtKB,
the University of Copenhagen DISEASES
database, Novoseek,
Genatlas, GeneTests,
GAD,
HuGE Navigator,
and/or TGDB.)
About This Section
|
HLA-DRB1 for disorders About GeneDecksing
OMIM gene information: 142857 OMIM disorders: 181000 126200 180300 UniProtKB/Swiss-Prot: 2B1G_HUMAN, Q29974
Genetic variation in HLA-DRB1 is a cause of susceptibility to sarcoidosis type 1 (SS1) [MIM:181000].Sarcoidosis is an idiopathic, systemic, inflammatory disease characterized by the formation of immune granulomas ininvolved organs. Granulomas predominantly invade the lungs and the lymphatic system, but also skin, liver, spleen,eyes and other organs may be involved 20/358 diseases for HLA-DRB1 (see all 358): About MalaCardsvogt-koyanagi-harada disease pure red-cell aplasia sarcoidosis, susceptibility l, 1 kleine-levin syndrome alpha 1-antitrypsin deficiency 21-hydroxylase deficiency graft versus host disease pars planitis adult-onset still's disease porphyria cutanea tarda polymyalgia rheumatica epidermolysis bullosa acquisita relapsing-remitting multiple sclerosis churg-strauss syndrome rhizomelic pseudopolyarthritis avascular necrosis of femoral head paroxysmal nocturnal hemoglobinuria toxic epidermal necrolysis chronic inflammatory demyelinating polyradiculoneuropathy stevens-johnson syndrome
9 diseases from the University of Copenhagen DISEASES database for HLA-DRB1:Hypersensitivity reaction type II disease Rheumatoid arthritis Diabetes mellitus Hyperthyroidism Connective tissue disease Thyroiditis Skin disease Leprosy Multiple sclerosis 10/53 Novoseek disease relationships for HLA-DRB1 gene (see all 53) About this table
| Disease |
-log (P-Val) |
Hits |
PubMed IDs for Articles with Shared Sentences (# sentences) |
| rheumatoid arthritis |
66.3 |
64 |
1416553 (3), 16277691 (2), 16385499 (2), 10765919 (2) (see all 44) |
| genetic susceptibility |
65.2 |
8 |
17055211 (1), 17047287 (1), 17309132 (1), 18004301 (1) (see all 8) |
| polymyalgia rheumatica |
58.1 |
10 |
10225816 (2), 8147928 (2), 9458210 (2), 15305244 (2) (see all 5) |
| diabetes mellitus insulin-dependent |
50.2 |
2 |
10680451 (1), 7817375 (1) |
| autoimmune diseases |
49.3 |
5 |
16362107 (1), 19117368 (1), 16198136 (1), 1617108 (1) (see all 5) |
| vogt-koyanagi-harada disease |
46.6 |
2 |
7906684 (1), 15603876 (1) |
| autoimmunity |
44.1 |
4 |
16385499 (1), 17987563 (1), 15120192 (1), 8675578 (1) |
| hepatitis autoimmune |
44 |
3 |
1350267 (2), 9672174 (1) |
| pemphigus foliaceus |
36.9 |
1 |
9027963 (1) |
| diabetes autoimmune |
35.6 |
2 |
10333055 (1), 18279373 (1) |
Genetic Association Database (GAD): HLA-DRB1 Human Genome Epidemiology (HuGE) Navigator: HLA-DRB1 (1845 documents) Export disorders for HLA-DRB1 gene to outside databases
|
Publications for HLA-DRB1 gene (in
PubMed.
Associations of this gene to articles via
1Entrez Gene,
2UniProtKB/Swiss-Prot,
3HGNC,
4GAD,
5PharmGKB,
6HMDB,
7DrugBank,
8UniProtKB/TrEMBL,
9 Novoseek, and/or
10fRNAdb)
About This Section
|
PubMed articles for HLA-DRB1 gene, integrated from 9 sources (see all 2487): (articles sorted by number of sources associating them with HLA-DRB1) | |  | Utopia: connect your pdf to the dynamic world of online information |
- [Determination of HLA-DRB1 gene polymorphism in Luoba ethnic group of Tibet] (PubMed id 15898419)1, 4, 9 Kang L.L....Li S.B. (2005)
- Influence of HLA-DRB1 and TNF microsatellite polymorphisms on the expression of extraarticular manifestations in rheumatoid arthritis patients from northwest Spain. (PubMed id 11791643)1, 4, 9 Mattey D.L....Ollier W.E. (2001)
- [Possible association between HLA-HRB1 and DQB1 genes frequency and susceptibility or resistance to Helicobacter pylori infection in Kunming Yi ethnic group children] (PubMed id 15833172)1, 4, 9 Huang Y.K....Zhou L.F. (2005)
- [Association of HLA-A, B, and DR haplotypes with genotype in Chinese children with systemic lupus erythematosus] (PubMed id 14748996)1, 4, 9 Li C.F....Jiang Z.F. (2003)
- [Polymorphism of length of tetranucleotide repeat from the 5'-side from the myelin basic protein gene in multiple sclerosis in Russians] (PubMed id 14714495)1, 4, 9 Andreevskii T.V....Favorova O.O. (2003)
- HLA-DRB1 and HLA-DQB1 polymorphisms in Pacific Islands populations. (PubMed id 12144623)1, 4, 9 Velickovic Z.M....Carter J.M. (2002)
- Collagenase-1 (MMP-1) and HLA-DRB1 gene polymorphisms in rheumatoid arthritis: a prospective longitudinal study. (PubMed id 11824952)1, 4, 9 Constantin A....Cantagrel A. (2002)
- Association between protein tyrosine phosphatase 22 variant R620W in conjunction with the HLA-DRB1 shared epitope and humoral autoimmunity to an immunodominant epitope of cartilage-specific type II collagen in early rheumatoid arthritis. (PubMed id 16385499)1, 4, 9 Burkhardt H....Reis A. (2006)
- [Polymorphism of HLA-A,-B and DRB1 in Han population of Shanxi province] (PubMed id 16215957)1, 4, 9 Lan T....Wang G.Q. (2005)
- The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis. (PubMed id 16277691)1, 4, 9 Turesson C....Matteson E.L. (2005)
|
External Searches for HLA-DRB1 gene
(in PubMed,
OMIM, and NCBI Bookshelf) About This Section
|
|
Genome Databases showing HLA-DRB1 gene
(According to
Entrez Gene,
HGNC,
AceView,
euGenes,
Ensembl,
miRBase,
ECgene,
Kegg,
and/or
H-InvDB)
About This Section
|
|
Other Databases showing HLA-DRB1 gene
(According to HUGE)
About This Section
| -- |
Specialized Databases showing HLA-DRB1 gene(According to PharmGKB,
ATLAS, HORDE, IMGT, LEIDEN, UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL, Wikipedia and/or GeneReviews via UniProtKB/Swiss-Prot) About This Section
|
| Name | Description |
| PharmGKB entry for HLA-DRB1 | Pharmacogenomics, SNPs, Pathways |
|
| | |
About This Section
| Patent Information for HLA-DRB1 gene: Search GeneIP for patents involving HLA-DRB1
GeneCards and IP: Japan Patent Office Licenses GeneCards European Patent Office Licenses GeneCards Improving the IP Search
|
Products for HLA-DRB1 gene(Antibodies, recombinant proteins, and assays from EMD Millipore, R&D Systems, OriGene, QIAGEN, GenScript, Cell Signaling Technology, SABiosciences, Novus Biologicals, Sino Biological, Enzo Life Sciences, Abcam, ProSpec, Uscn, Thermo Fisher Scientific, Gene Editing from DNA2.0 and Sirion Biotech, Clones from EMD Millipore, OriGene, GenScript, Sino Biological, DNA2.0, SwitchGear Genomics, Vector BioLabs, Cell lines from GenScript, LifeMap BioReagents, and Sirion Biotech, PCR Arrays from SABiosciences, Drugs and/or compounds from EMD Millipore, Tocris Bioscience, and/or
Enzo Life Sciences, In Situ Hybridization Assays from Advanced Cell Diagnostics, Animal models from inGenious Targeting Laboratory) About This Section
|
 | |
 | |
 |
| | | | OriGene Antibodies for HLA-DRB1 | | OriGene shRNA RFP for HLA-DRB1 | | OriGene 29mer shRNA kits in GFP-retroviral vector in human, mouse, rat for HLA-DRB1 | | OriGene genome-wide validated SYBR primer pairs in human, mouse, rat for HLA-DRB1 | | OriGene Protein Over-expression Lysate for HLA-DRB1 | | Browse OriGene Fluorogenic Cell Assay Kits | | OriGene siRNA for HLA-DRB1 | | OriGene 3'-UTR Clone for HLA-DRB1 | | OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for HLA-DRB1 | | OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for HLA-DRB1 | | Browse OriGene GFP tagged cDNA clones in CMV expression vector | | Browse OriGene MicroRNA Expression Plasmids | | Browse OriGene basic RS shRNAs | | Browse OriGene validated miRNA SYBR primer pairs | | OriGene Purified Protein for HLA-DRB1 | | OriGene custom cloning services - gene synthesis, subcloning, mutagenesis,
variant library, vector shuttling | | OriGene Custom Antibody Services for HLA-DRB1 | | OriGene Custom Protein Services for HLA-DRB1 | | OriGene Custom Immunoassay Development | | |
| |  |
 |
| | QIAGEN Custom miScript Target Protector blocks miRNA-binding site of in human, mouse, rat HLA-DRB1 | | Search QIAGEN SeqTarget long-range PCR primers in human, mouse, rat for resequencing HLA-DRB1 | | QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat HLA-DRB1 | | QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat HLA-DRB1 | | QIAGEN QuantiFast Probe-based Assays in human, mouse, rat HLA-DRB1 | | QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat HLA-DRB1 |
| |
 |  |  |  | |
| | | |  |  |  |  | | | | |
 |
 |
 |
 | | HLA-DRB1 Proteins, Antibodies, CLIAs, and ELISAs |
| | | | Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for HLA-DRB1 |
|  |  |  |  | | | Search ThermoFisher Antibodies for HLA-DRB1 |
| | Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat HLA-DRB1 |
| |  | |
|
|
|